Nucleolin	B-protein
is	O
one	O
component	O
of	O
the	O
B	B-protein
cell-specific	I-protein
transcription	I-protein
factor	I-protein
and	O
switch	B-protein
region	I-protein
binding	I-protein
protein	I-protein
,	O
LR1	B-protein
.	O

LR1	B-protein
is	O
a	O
B	O
cell-specific	O
,	O
sequence-specific	O
DNA	O
binding	O
activity	O
that	O
regulates	O
transcription	O
in	O
activated	B-cell_type
B	I-cell_type
cells	I-cell_type
.	O

LR1	B-protein
also	O
binds	O
Ig	B-protein
heavy	I-protein
chain	I-protein
switch	O
region	O
sequences	O
and	O
may	O
function	O
in	O
class	O
switch	O
recombination	O
.	O

LR1	B-protein
contains	O
two	O
polypeptides	O
,	O
of	O
106	O
kDa	O
and	O
45	O
kDa	O
,	O
and	O
here	O
we	O
report	O
that	O
the	O
106-kDa	B-protein
component	I-protein
of	O
LR1	B-protein
is	O
nucleolin	B-protein
.	O

This	O
identification	O
,	O
initially	O
made	O
by	O
microsequence	O
analysis	O
,	O
was	O
verified	O
by	O
showing	O
that	O
(	O
i	O
)	O
LR1	B-protein
-DNA	O
binding	O
activity	O
increased	O
in	O
B	B-cell_type
cells	I-cell_type
transfected	O
with	O
a	O
nucleolin	B-DNA
cDNA	I-DNA
expression	I-DNA
construct	I-DNA
;	O
(	O
ii	O
)	O
LR1	B-protein
-DNA	O
binding	O
activity	O
was	O
recognized	O
by	O
antibodies	O
raised	O
against	O
recombinant	B-protein
human	I-protein
nucleolin	I-protein
;	O
and	O
(	O
iii	O
)	O
in	O
B	B-cell_type
cells	I-cell_type
transfected	O
with	O
epitope-tagged	B-DNA
nucleolin	I-DNA
expression	I-DNA
constructs	I-DNA
,	O
the	O
LR1-DNA	B-protein
complex	I-protein
was	O
recognized	O
by	O
the	O
anti-tag	B-protein
antibody	I-protein
.	O

Nucleolin	B-protein
is	O
an	O
abundant	B-protein
nucleolar	I-protein
protein	I-protein
which	O
is	O
believed	O
to	O
play	O
a	O
role	O
in	O
rDNA	B-DNA
transcription	O
or	O
organization	O
,	O
or	O
rRNA	B-RNA
processing	O
.	O

Homology	O
between	O
nucleolin	B-protein
and	O
histone	B-protein
H1	I-protein
suggests	O
that	O
nucleolin	B-protein
may	O
alter	O
DNA	O
organization	O
in	O
response	O
to	O
cell	O
cycle	O
controls	O
,	O
and	O
the	O
nucleolin	B-protein
component	O
of	O
LR1	B-protein
may	O
therefore	O
function	O
to	O
organize	O
switch	B-DNA
regions	I-DNA
before	O
,	O
during	O
,	O
or	O
after	O
switch	O
recombination	O
.	O

The	O
demonstration	O
that	O
nucleolin	B-protein
is	O
a	O
component	O
of	O
a	O
B	B-protein
cell-specific	I-protein
complex	I-protein
that	O
binds	O
switch	O
region	O
sequences	O
suggests	O
that	O
the	O
G-rich	B-DNA
switch	I-DNA
regions	I-DNA
may	O
have	O
evolved	O
from	O
rDNA	B-DNA
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

94	NULL
,	NULL
pp	NULL
.	NULL

3605-3610	NULL
,	NULL
April	NULL
1997	NULL
Biochemistry	NULL
Nucleolin	NULL
is	NULL
one	NULL
component	NULL
of	NULL
the	NULL
B	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
and	NULL
switch	NULL
region	NULL
binding	NULL
protein	NULL
,	NULL
LR1l	NULL
(	NULL
Ig	NULL
/rDNA/recombination	NULL
)	NULL
L.	NULL
A.	NULL
HANAKAHI®*	NULL
,	NULL
LAURIE	NULL
A.	NULL
DempsEy*	NULL
,	NULL
MincG-JIE	NULL
L*	NULL
,	NULL
aAnp	NULL
Nancy	NULL
MaizeLs*t*	NULL
Departments	NULL
of	NULL
*Molecular	NULL
Biophysics	NULL
and	NULL
Biochemistry	NULL
and	NULL
*Genetics	NULL
,	NULL
Yale	NULL
University	NULL
,	NULL
266	NULL
Whitney	NULL
Avenue	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
06520-8114	NULL
Communicated	NULL
by	NULL
Joan	NULL
A.	NULL
Steitz	NULL
,	NULL
Yale	NULL
University	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
,	NULL
January	NULL
16	NULL
,	NULL
1997	NULL
(	NULL
received	NULL
for	NULL
review	NULL
December	NULL
2	NULL
,	NULL
1996	NULL
)	NULL
ABSTRACT	NULL
LR1	NULL
is	NULL
a	NULL
B	NULL
cell-specific	NULL
,	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
activity	NULL
that	NULL
regulates	NULL
transcription	NULL
in	NULL
activated	NULL
B	NULL
cells	NULL
.	NULL

LR1	NULL
also	NULL
binds	NULL
Ig	NULL
heavy	NULL
chain	NULL
switch	NULL
region	NULL
sequences	NULL
and	NULL
may	NULL
function	NULL
in	NULL
class	NULL
switch	NULL
recombination	NULL
.	NULL

LR1	NULL
contains	NULL
two	NULL
polypeptides	NULL
,	NULL
of	NULL
106	NULL
kDa	NULL
and	NULL
45	NULL
kDa	NULL
,	NULL
and	NULL
here	NULL
we	NULL
report	NULL
that	NULL
the	NULL
106-kDa	NULL
component	NULL
of	NULL
LR1	NULL
is	NULL
nucleolin	NULL
.	NULL

This	NULL
iden-tification	NULL
,	NULL
initially	NULL
made	NULL
by	NULL
microsequence	NULL
analysis	NULL
,	NULL
was	NULL
verified	NULL
by	NULL
showing	NULL
that	NULL
(	NULL
?	NULL
)	NULL

LR1-DNA	NULL
binding	NULL
activity	NULL
increased	NULL
in	NULL
B	NULL
cells	NULL
transfected	NULL
with	NULL
a	NULL
nucleolin	NULL
cDNA	NULL
expression	NULL
construct	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
LR1-DNA	NULL
binding	NULL
activity	NULL
was	NULL
recognized	NULL
by	NULL
antibodies	NULL
raised	NULL
against	NULL
recombinant	NULL
human	NULL
nucleolin	NULL
;	NULL
and	NULL
(	NULL
iii	NULL
)	NULL
in	NULL
B	NULL
cells	NULL
transfected	NULL
with	NULL
epitope-tagged	NULL
nucleolin	NULL
expression	NULL
constructs	NULL
,	NULL
the	NULL
LR1-DNA	NULL
complex	NULL
was	NULL
recognized	NULL
by	NULL
the	NULL
anti-tag	NULL
antibody	NULL
.	NULL

Nucleolin	NULL
is	NULL
an	NULL
abundant	NULL
nucleolar	NULL
protein	NULL
which	NULL
is	NULL
believed	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
rDNA	NULL
transcription	NULL
or	NULL
organization	NULL
,	NULL
or	NULL
rRNA	NULL
processing	NULL
.	NULL

Homology	NULL
between	NULL
nucleolin	NULL
and	NULL
histone	NULL
H1	NULL
suggests	NULL
that	NULL
nucleolin	NULL
may	NULL
alter	NULL
DNA	NULL
organization	NULL
in	NULL
response	NULL
to	NULL
cell	NULL
cycle	NULL
controls	NULL
,	NULL
and	NULL
the	NULL
nucleolin	NULL
component	NULL
of	NULL
LR1	NULL
may	NULL
therefore	NULL
function	NULL
to	NULL
organize	NULL
switch	NULL
regions	NULL
before	NULL
,	NULL
during	NULL
,	NULL
or	NULL
after	NULL
switch	NULL
recombination	NULL
.	NULL

The	NULL
demonstration	NULL
that	NULL
nucleolin	NULL
is	NULL
a	NULL
component	NULL
of	NULL
a	NULL
B	NULL
cell-specific	NULL
complex	NULL
that	NULL
binds	NULL
switch	NULL
region	NULL
sequences	NULL
suggests	NULL
that	NULL
the	NULL
G-rich	NULL
switch	NULL
regions	NULL
may	NULL
have	NULL
evolved	NULL
from	NULL
rDNA	NULL
.	NULL

LR1	NULL
is	NULL
a	NULL
B	NULL
cell-specific	NULL
,	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

It	NULL
was	NULL
first	NULL
identified	NULL
as	NULL
a	NULL
factor	NULL
that	NULL
specifically	NULL
recognizes	NULL
Ig	NULL
switch	NULL
region	NULL
sequences	NULL
and	NULL
is	NULL
induced	NULL
in	NULL
primary	NULL
B	NULL
cells	NULL
activated	NULL
to	NULL
carry	NULL
out	NULL
class	NULL
switch	NULL
recombination	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

LR1	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
regulate	NULL
transcription	NULL
of	NULL
two	NULL
genes	NULL
that	NULL
function	NULL
in	NULL
B	NULL
cell	NULL
transformation	NULL
,	NULL
c-myc	NULL
(	NULL
3	NULL
)	NULL
and	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
EBNA-1	NULL
gene	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
Ig	NULL
switch	NULL
recombination	NULL
,	NULL
one	NULL
constant	NULL
region	NULL
is	NULL
literally	NULL
switched	NULL
for	NULL
another	NULL
by	NULL
joining	NULL
a	NULL
rearranged	NULL
and	NULL
expressed	NULL
variable	NULL
region	NULL
to	NULL
a	NULL
downstream	NULL
constant	NULL
region	NULL
,	NULL
deleting	NULL
a	NULL
long	NULL
region	NULL
of	NULL
intervening	NULL
DNA	NULL
.	NULL

Switching	NULL
involves	NULL
repetitive	NULL
,	NULL
G-rich	NULL
regions	NULL
of	NULL
DNA	NULL
,	NULL
called	NULL
switch	NULL
regions	NULL
(	NULL
S	NULL
regions	NULL
)	NULL
,	NULL
that	NULL
are	NULL
found	NULL
upstream	NULL
of	NULL
the	NULL
constant	NULL
regions	NULL
that	NULL
undergo	NULL
switch	NULL
recombination	NULL
(	NULL
5-7	NULL
)	NULL
.	NULL

A	NULL
specific	NULL
S	NULL
region	NULL
is	NULL
targeted	NULL
for	NULL
recombination	NULL
by	NULL
induction	NULL
of	NULL
noncoding	NULL
transcripts	NULL
from	NULL
a	NULL
promoter	NULL
upstream	NULL
of	NULL
that	NULL
S	NULL
region	NULL
(	NULL
8-14	NULL
)	NULL
,	NULL
and	NULL
recombination	NULL
depends	NULL
on	NULL
both	NULL
transcription	NULL
and	NULL
splicing	NULL
of	NULL
these	NULL
switch	NULL
transcript	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Since	NULL
S	NULL
region	NULL
transcription	NULL
is	NULL
prerequisite	NULL
to	NULL
recombination	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
LR1	NULL
binding	NULL
to	NULL
sites	NULL
in	NULL
the	NULL
S	NULL
regions	NULL
might	NULL
potentiate	NULL
S	NULL
region	NULL
transcription	NULL
and	NULL
thereby	NULL
activate	NULL
recombination	NULL
.	NULL

In	NULL
vitro	NULL
DNA	NULL
binding	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
LR1-DNA	NULL
binding	NULL
consensus	NULL
,	NULL
GGNC-NAG	NULL
(	NULL
G/C	NULL
)	NULL
JCTG	NULL
(	NULL
G/A	NULL
)	NULL
,	NULL
is	NULL
loose	NULL
,	NULL
and	NULL
LR1	NULL
may	NULL
bind	NULL
multiple	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

Copyright	NULL
©	NULL
1997	NULL
by	NULL
Tar	NULL
Narronat	NULL
Acapemy	NULL
or	NULL
Sciences	NULL
or	NULL
THE	NULL
USA	NULL
0027-8424	NULL
/97/943605-6	NULL
$	NULL
2.00	NULL
/0	NULL
PNAS	NULL
is	NULL
available	NULL
online	NULL
at	NULL
http	NULL
:	NULL
//www.pnas.org	NULL
.	NULL

3605	NULL
sites	NULL
in	NULL
each	NULL
of	NULL
the	NULL
G-rich	NULL
S	NULL
regions	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
another	NULL
possible	NULL
function	NULL
for	NULL
LR1	NULL
could	NULL
be	NULL
to	NULL
organize	NULL
S	NULL
region	NULL
DNA	NULL
before	NULL
,	NULL
during	NULL
,	NULL
or	NULL
after	NULL
recombination	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
function	NULL
of	NULL
LR1	NULL
,	NULL
we	NULL
have	NULL
purified	NULL
and	NULL
characterized	NULL
the	NULL
activity	NULL
.	NULL

LR1	NULL
is	NULL
a	NULL
complex	NULL
of	NULL
two	NULL
polypeptides	NULL
,	NULL
of	NULL
106	NULL
kDa	NULL
and	NULL
45	NULL
kDa	NULL
(	NULL
2	NULL
,	NULL
16	NULL
)	NULL
.	NULL

In	NULL
this	NULL
communication	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
106-kDa	NULL
polypeptide	NULL
component	NULL
of	NULL
LR1	NULL
is	NULL
nucleolin	NULL
.	NULL

Nucleolin	NULL
is	NULL
an	NULL
abundant	NULL
and	NULL
highly	NULL
modified	NULL
protein	NULL
found	NULL
in	NULL
nucleoli	NULL
,	NULL
the	NULL
centers	NULL
of	NULL
ribosome	NULL
biogenesis	NULL
(	NULL
17-22	NULL
)	NULL
.	NULL

Its	NULL
N	NULL
terminus	NULL
is	NULL
homologous	NULL
to	NULL
histone	NULL
H1	NULL
,	NULL
and	NULL
like	NULL
many	NULL
RNA-binding	NULL
proteins	NULL
,	NULL
nucleolin	NULL
contains	NULL
both	NULL
RNA	NULL
recognition	NULL
motifs	NULL
(	NULL
RRM	NULL
)	NULL
and	NULL
Arg-Gly-Gly	NULL
(	NULL
RGG	NULL
)	NULL
motifs	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
similarity	NULL
between	NULL
nucleolin	NULL
and	NULL
histone	NULL
H1	NULL
has	NULL
suggested	NULL
that	NULL
one	NULL
role	NULL
of	NULL
nucleolin	NULL
in	NULL
the	NULL
nucleolus	NULL
may	NULL
be	NULL
to	NULL
determine	NULL
rDNA	NULL
architecture	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
;	NULL
and	NULL
nucleolin	NULL
may	NULL
function	NULL
analogously	NULL
in	NULL
switching	NULL
,	NULL
organizing	NULL
S	NULL
region	NULL
DNA	NULL
before	NULL
,	NULL
during	NULL
,	NULL
or	NULL
after	NULL
recombination	NULL
in	NULL
response	NULL
to	NULL
cell	NULL
cycle	NULL
controls	NULL
.	NULL

Nucleolin	NULL
has	NULL
also	NULL
been	NULL
thought	NULL
to	NULL
regulate	NULL
rDNA	NULL
expression	NULL
;	NULL
and	NULL
the	NULL
results	NULL
we	NULL
report	NULL
provide	NULL
the	NULL
first	NULL
conclusive	NULL
evidence	NULL
for	NULL
participation	NULL
of	NULL
nucleolin	NULL
in	NULL
a	NULL
transcription	NULL
factor	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
observation	NULL
that	NULL
nucleolin	NULL
is	NULL
a	NULL
component	NULL
of	NULL
a	NULL
factor	NULL
that	NULL
binds	NULL
specifically	NULL
to	NULL
S	NULL
regions	NULL
suggests	NULL
that	NULL
S	NULL
regions	NULL
and	NULL
rDNA	NULL
are	NULL
evolutionarily	NULL
related	NULL
.	NULL

This	NULL
possibility	NULL
is	NULL
in	NULL
accord	NULL
with	NULL
early	NULL
reports	NULL
of	NULL
sequence	NULL
homology	NULL
between	NULL
rDNA	NULL
and	NULL
portions	NULL
of	NULL
the	NULL
Ig	NULL
heavy	NULL
chain	NULL
locus	NULL
(	NULL
25	NULL
)	NULL
and	NULL
with	NULL
functional	NULL
studies	NULL
showing	NULL
that	NULL
rDNA	NULL
may	NULL
have	NULL
special	NULL
properties	NULL
in	NULL
recombination	NULL
(	NULL
26-28	NULL
)	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Purification	NULL
of	NULL
LR1	NULL
.	NULL

LR1	NULL
was	NULL
purified	NULL
from	NULL
the	NULL
human	NULL
Epstein-Barr	NULL
virus-transformed	NULL
B	NULL
cell	NULL
line	NULL
,	NULL
Raji	NULL
.	NULL

Nuclear	NULL
extract	NULL
(	NULL
29	NULL
)	NULL
from	NULL
40	NULL
L	NULL
of	NULL
cells	NULL
was	NULL
incubated	NULL
with	NULL
20	NULL
ng/ml	NULL
of	NULL
biotinylated	NULL
duplex	NULL
DNA	NULL
carrying	NULL
the	NULL
§y1	NULL
LR1	NULL
binding	NULL
site	NULL
(	NULL
1	NULL
)	NULL
and	NULL
,	NULL
as	NULL
nonspecific	NULL
competitor	NULL
,	NULL
2	NULL
ug/ml	NULL
sonicated	NULL
,	NULL
boiled	NULL
Escherichia	NULL
coli	NULL
DNA	NULL
,	NULL
in	NULL
buffer	NULL
L	NULL
containing	NULL
0.2	NULL
M	NULL
KCl	NULL
;	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
captured	NULL
on	NULL
streptavidin	NULL
aga-rose	NULL
(	NULL
30	NULL
)	NULL
;	NULL
and	NULL
protein	NULL
was	NULL
eluted	NULL
with	NULL
0.6	NULL
M	NULL
KCL	NULL
in	NULL
buffer	NULL
L	NULL
(	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.5/2	NULL
mM	NULL
EDTA/10	NULL
%	NULL
glycerol/1	NULL
mM	NULL
DTT/1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride/10	NULL
pg/ml	NULL
leupep-tin/5	NULL
ug/ml	NULL
benzamidine/5	NULL
pg/ml	NULL
pepstatin	NULL
A/5	NULL
pg/ml	NULL
apro-tinin	NULL
)	NULL
.	NULL

The	NULL
eluate	NULL
was	NULL
dialyzed	NULL
in	NULL
buffer	NULL
L	NULL
containing	NULL
0.1	NULL
M	NULL
KCl	NULL
and	NULL
chromatographed	NULL
on	NULL
DEAE-Sepharose	NULL
using	NULL
a	NULL
gradient	NULL
of	NULL
0.1-1.0	NULL
M	NULL
KC	NULL
in	NULL
buffer	NULL
L.	NULL
Fractions	NULL
with	NULL
LR1-DNA	NULL
binding	NULL
activity	NULL
eluted	NULL
between	NULL
0.45-0.6	NULL
M	NULL
KCI	NULL
and	NULL
contained	NULL
106	NULL
kDa	NULL
and	NULL
45	NULL
kDa	NULL
polypeptides	NULL
,	NULL
as	NULL
observed	NULL
previously	NULL
(	NULL
2	NULL
)	NULL
.	NULL

The	NULL
106-kDa	NULL
species	NULL
was	NULL
isolated	NULL
by	NULL
preparative	NULL
SDS/PAGE	NULL
and	NULL
submitted	NULL
in	NULL
the	NULL
gel	NULL
slice	NULL
to	NULL
the	NULL
W.	NULL
M.	NULL
Keck	NULL
Foundation	NULL
,	NULL
Yale	NULL
Medical	NULL
School	NULL
,	NULL
where	NULL
proteolysis	NULL
with	NULL
endoprotease	NULL
lys	NULL
C	NULL
and	NULL
peptide	NULL
sequence	NULL
analysis	NULL
were	NULL
carried	NULL
out	NULL
.	NULL

Aware	NULL
that	NULL
nucleolin	NULL
might	NULL
copurify	NULL
as	NULL
a	NULL
contaminant	NULL
,	NULL
we	NULL
generated	NULL
Abbreviations	NULL
:	NULL
CMV	NULL
,	NULL
cytomegalovirus	NULL
;	NULL
S	NULL
region	NULL
,	NULL
switch	NULL
region	NULL
;	NULL
RRM	NULL
,	NULL
RNA	NULL
recognition	NULL
motif	NULL
;	NULL
HA	NULL
,	NULL
hemagglutinin	NULL
.	NULL

#	NULL
To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

e-mail	NULL
:	NULL
nancy	NULL
.	NULL

maizels	NULL
@	NULL
quickmail.yale.edu	NULL
.	NULL

3606	NULL
Biochemistry	NULL
:	NULL
Hanakahi	NULL
et	NULL
al	NULL
.	NULL

A	NULL
.	NULL

1	NULL
VKLAKAGKNQ	NULL
GDPKKMAPPP	NULL
KEVEEDSEDE	NULL
EMSEDEEDDS	NULL
SGEEVVIPOQK	NULL
51	NULL
KGKKAAATSA	NULL
KKVVVSPTKK	NULL
VAVATPAKKA	NULL
AVTPGKKAAA	NULL
TPAKKTVTPA	NULL
101	NULL
KAVTTPGKKG	NULL
ATPGKALVAT	NULL
PGKKCAAIPA	NULL
KGAKNGKNAK	NULL
KEDSDEEEDD	NULL
151	NULL
DSEEDEEDDE	NULL
DEDEDEDEIE	NULL
PAAMKAAAAA	NULL
PASEDEDDED	NULL
DEDDEDDDDD	NULL
201	NULL
EEDDSEEEAM	NULL
ETTPAKGKKA	NULL
AKVVPVKAKN	NULL
VAEDEDEEED	NULL
DEDEDDDDDE	NULL
251	NULL
DDEDDDDEDD	NULL
EEEEEEEEEE	NULL
PVKEAPGKRK	NULL
KEMAKQKAAP	NULL
EAKKQKVEGT	NULL
301	NULL
EPTTAFNLFV	NULL
GNLNFNKSAP	NULL
ELKTGISDVF	NULL
AKNDLAVVDY	NULL
RIGMTRKFGY	NULL
351	NULL
VDFESAEDLE	NULL
KALELTGLKV	NULL
FGNEIKLEKP	NULL
KGKDSKKERD	NULL
ARTLLAKNLP	NULL
401	NULL
YKVTQDELKE	NULL
VFEDAAEIRL	NULL
VSKDGKSKGI	NULL
AYIEFKTEAD	NULL
AEKTFEEKQG	NULL
451	NULL
TEIDGRSISL	NULL
YYTGEKGQNQ	NULL
DYRGGKNSTW	NULL
SGESKTLVLS	NULL
NLSYSATERT	NULL
501	NULL
LQEVFEKATF	NULL
IKVPQNQNGK	NULL
SKGYAFIEFA	NULL
SFEDAKEALN	NULL
SCNKREIEGR	NULL
551	NULL
ATRLELOGPR	NULL
GSPNARSQPS	NULL
KTLFVKGLSE	NULL
DTTEETLKES	NULL
FDGSVRARIV	NULL
601	NULL
TDRETGSSKG	NULL
FGFVDFNSEE	NULL
DAKAAKEAME	NULL
DGEIDGNKVT	NULL
LDWAKPKGEG	NULL
651	NULL
GFGGRGGGRG	NULL
GFGGRGGGRG	NULL
GRGGFGGRGR	NULL
GGFGGRGGFR	NULL
GGRGGGCDHK	NULL
701	NULL
-	NULL
PQGKKTKFE	NULL
B.	NULL
aca	NULL
enessess	NULL
ecr-r	NULL
[	NULL
_	NULL
000000300	NULL
'	NULL
H1-ike	NULL
'	NULL
RRMs	NULL
'rea	NULL
'	NULL
C	NULL
&	NULL
(	NULL
D	NULL
,	NULL
E	NULL
)	NULL
n	NULL
e	NULL
TPXKK	NULL
(	NULL
cde2	NULL
kinase	NULL
)	NULL
[	NULL
G	NULL
]	NULL
nudear	NULL
localization	NULL
0	NULL
N-glycosylation	NULL
comme	NULL
»	NULL
_	NULL
RRM	NULL
0	NULL
dimethylarginine	NULL
FiG	NULL
.	NULL

1	NULL
.	NULL

Nucleolin	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Predicted	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
human	NULL
nucleolin	NULL
.	NULL

Residues	NULL
624-626	NULL
were	NULL
omitted	NULL
from	NULL
the	NULL
original	NULL
published	NULL
report	NULL
(	NULL
GenBank	NULL
file	NULL
humnucleo	NULL
,	NULL
accession	NULL
number	NULL
JO5584	NULL
;	NULL
ref	NULL
.	NULL

22	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Schematic	NULL
of	NULL
nucleolin	NULL
,	NULL
showing	NULL
the	NULL
histone	NULL
H1-like	NULL
N-terminal	NULL
region	NULL
,	NULL
which	NULL
includes	NULL
long	NULL
runs	NULL
of	NULL
acidic	NULL
amino	NULL
acids	NULL
and	NULL
sites	NULL
for	NULL
edc2	NULL
kinase	NULL
;	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
and	NULL
N-glycosylation	NULL
sites	NULL
;	NULL
the	NULL
four	NULL
RRMs	NULL
;	NULL
and	NULL
the	NULL
RGG	NULL
motifs	NULL
in	NULL
the	NULL
C	NULL
terminus	NULL
.	NULL

highly	NULL
purified	NULL
LR1	NULL
from	NULL
the	NULL
murine	NULL
pre-B	NULL
cell	NULL
line	NULL
,	NULL
PD31	NULL
.	NULL

Attempts	NULL
to	NULL
remove	NULL
nucleolin	NULL
in	NULL
the	NULL
first	NULL
purification	NULL
step	NULL
by	NULL
DEAE	NULL
chromatography	NULL
resulted	NULL
in	NULL
loss	NULL
of	NULL
more	NULL
than	NULL
90	NULL
%	NULL
of	NULL
LR1-DNA	NULL
binding	NULL
activity	NULL
,	NULL
suggesting	NULL
that	NULL
,	NULL
at	NULL
least	NULL
in	NULL
nuclear	NULL
extracts	NULL
,	NULL
nucleolin	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
LR1-DNA	NULL
binding	NULL
activity	NULL
.	NULL

Instead	NULL
,	NULL
nuclear	NULL
extract	NULL
(	NULL
31	NULL
)	NULL
from	NULL
40	NULL
L	NULL
of	NULL
cells	NULL
was	NULL
fractioned	NULL
first	NULL
on	NULL
Heparin	NULL
Hi-Trap	NULL
;	NULL
then	NULL
by	NULL
oligonucleotide	NULL
capture	NULL
,	NULL
as	NULL
described	NULL
above	NULL
;	NULL
then	NULL
on	NULL
Mono	NULL
Q	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
using	NULL
a	NULL
0.05-1.0	NULL
M	NULL
NaCl	NULL
gradient	NULL
.	NULL

Activity	NULL
assays	NULL
and	NULL
immunoblotting	NULL
showed	NULL
that	NULL
most	NULL
(	NULL
90	NULL
%	NULL
)	NULL
of	NULL
the	NULL
LR1-DNA	NULL
binding	NULL
activity	NULL
flowed	NULL
through	NULL
Mono	NULL
Q	NULL
,	NULL
while	NULL
most	NULL
(	NULL
>	NULL
95	NULL
%	NULL
)	NULL
of	NULL
the	NULL
nucleolin	NULL
eluted	NULL
at	NULL
0.4	NULL
M	NULL
NaCl	NULL
,	NULL
as	NULL
reported	NULL
by	NULL
others	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
flow-through	NULL
from	NULL
the	NULL
Mono	NULL
Q	NULL
column	NULL
was	NULL
then	NULL
subjected	NULL
to	NULL
Mono	NULL
S	NULL
chromatography	NULL
,	NULL
using	NULL
a	NULL
0.05-1.0	NULL
M	NULL
NaCl	NULL
gradient	NULL
,	NULL
and	NULL
binding	NULL
activity	NULL
eluted	NULL
at	NULL
about	NULL
0.33	NULL
M	NULL
NaCl	NULL
.	NULL

At	NULL
this	NULL
point	NULL
the	NULL
preparation	NULL
was	NULL
estimated	NULL
to	NULL
be	NULL
at	NULL
least	NULL
12,000-fold	NULL
purified	NULL
.	NULL

The	NULL
purified	NULL
preparation	NULL
,	NULL
which	NULL
specifically	NULL
bound	NULL
to	NULL
duplex	NULL
DNA	NULL
carrying	NULL
an	NULL
LR1	NULL
site	NULL
DNA	NULL
(	NULL
K4	NULL
~	NULL
5	NULL
X	NULL
10-	NULL
!	NULL

°	NULL
M	NULL
)	NULL
,	NULL
contained	NULL
polypeptides	NULL
of	NULL
106	NULL
kDa	NULL
and	NULL
45	NULL
kDa	NULL
.	NULL

Immunoblotting	NULL
showed	NULL
the	NULL
106-kDa	NULL
polypeptide	NULL
to	NULL
be	NULL
nucleolin	NULL
.	NULL

The	NULL
45-kDa	NULL
species	NULL
was	NULL
not	NULL
recognized	NULL
by	NULL
antinucleolin	NULL
antibodies	NULL
and	NULL
is	NULL
a	NULL
distinct	NULL
polypeptide	NULL
species	NULL
(	NULL
unpublished	NULL
work	NULL
)	NULL
.	NULL

Constructs	NULL
and	NULL
Transfections	NULL
.	NULL

Nucleolin	NULL
constructs	NULL
were	NULL
generated	NULL
from	NULL
a	NULL
human	NULL
nucleolin	NULL
cDNA	NULL
clone	NULL
,	NULL
generously	NULL
provided	NULL
by	NULL
M.	NULL
Srivastava	NULL
(	NULL
22	NULL
)	NULL
,	NULL
which	NULL
we	NULL
subcloned	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
pBS/KS*	NULL
(	NULL
Stratagene	NULL
)	NULL
to	NULL
create	NULL
pBSNuc	NULL
.	NULL

For	NULL
production	NULL
of	NULL
recombinant	NULL
protein	NULL
in	NULL
£	NULL
.	NULL

coli	NULL
,	NULL
an	NULL
Nrul/MscI	NULL
fragment	NULL
was	NULL
deleted	NULL
from	NULL
pBSNuc	NULL
,	NULL
leaving	NULL
residues	NULL
284-709	NULL
of	NULL
nucleolin	NULL
,	NULL
which	NULL
was	NULL
then	NULL
cloned	NULL
as	NULL
an	NULL
EcoRI	NULL
fragment	NULL
into	NULL
the	NULL
pMalc2	NULL
vector	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
to	NULL
create	NULL
pMalNuc	NULL
.	NULL

To	NULL
express	NULL
nucleolin	NULL
under	NULL
control	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
promoter	NULL
,	NULL
the	NULL
Xbal/EcoRV	NULL
fragment	NULL
from	NULL
pBSNuc	NULL
was	NULL
ligated	NULL
into	NULL
Spel	NULL
pCMV2R	NULL
to	NULL
generate	NULL
pNFor4	NULL
;	NULL
pCMV2R	NULL
is	NULL
a	NULL
derivative	NULL
of	NULL
pCMV	NULL
B	NULL
(	NULL
CLONTECH	NULL
)	NULL
into	NULL
which	NULL
the	NULL
NofI/Rseal	NULL
fragment	NULL
of	NULL
the	NULL
pBS/KS*	NULL
polylinker	NULL
has	NULL
been	NULL
inserted	NULL
at	NULL
the	NULL
NotI	NULL
site	NULL
.	NULL

A	NULL
triple	NULL
repeat	NULL
of	NULL
the	NULL
hemagglutinin	NULL
(	NULL
HA	NULL
)	NULL
epitope	NULL
tag	NULL
YPYDVPDYAG	NULL
(	NULL
gift	NULL
from	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
D.	NULL
Gonda	NULL
,	NULL
Yale	NULL
Medical	NULL
School	NULL
)	NULL
was	NULL
inserted	NULL
into	NULL
nucleolin	NULL
after	NULL
amino	NULL
acid	NULL
4	NULL
by	NULL
amplification	NULL
of	NULL
DNA	NULL
encoding	NULL
the	NULL
triple	NULL
tag	NULL
with	NULL
PCR	NULL
primers	NULL
incorporating	NULL
EcoRV	NULL
sites	NULL
,	NULL
and	NULL
ligation	NULL
of	NULL
the	NULL
EcoRV-digested	NULL
PCR	NULL
product	NULL
into	NULL
the	NULL
NruI	NULL
site	NULL
of	NULL
pBSNuc	NULL
.	NULL

The	NULL
tagged	NULL
cDNA	NULL
was	NULL
cloned	NULL
as	NULL
an	NULL
Xbel/EcoRV	NULL
fragment	NULL
into	NULL
pCMV2R	NULL
to	NULL
create	NULL
pNtagd4	NULL
.	NULL

All	NULL
PCR-generated	NULL
regions	NULL
in	NULL
clones	NULL
were	NULL
sequenced	NULL
throughout	NULL
their	NULL
length	NULL
.	NULL

PD31	NULL
murine	NULL
pre-B	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
Qiagen	NULL
(	NULL
Chats-worth	NULL
,	NULL
CA	NULL
)	NULL
purified	NULL
plasmid	NULL
,	NULL
as	NULL
described	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
made	NULL
40-48	NULL
hr	NULL
later	NULL
by	NULL
extraction	NULL
with	NULL
1	NULL
M	NULL
KCI	NULL
(	NULL
31	NULL
)	NULL
and	NULL
protein	NULL
concentration	NULL
measured	NULL
by	NULL
Bradford	NULL
assay	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
HA	NULL
tag	NULL
was	NULL
confirmed	NULL
by	NULL
immunoblots	NULL
of	NULL
transfected	NULL
cell	NULL
extracts	NULL
using	NULL
the	NULL
HA	NULL
tag-specific	NULL
mAb	NULL
,	NULL
12CAS	NULL
.	NULL

Antibodies	NULL
,	NULL
Immunofluorescent	NULL
Staining	NULL
,	NULL
and	NULL
Immunoblot-ting	NULL
.	NULL

Antinucleolin	NULL
antibodies	NULL
were	NULL
raised	NULL
against	NULL
a	NULL
maltose	NULL
binding	NULL
protein	NULL
fusion	NULL
protein	NULL
containing	NULL
amino	NULL
acids	NULL
284-709	NULL
of	NULL
human	NULL
nucleolin	NULL
,	NULL
which	NULL
corresponds	NULL
to	NULL
the	NULL
RRM	NULL
and	NULL
RGG	NULL
domains	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Extract	NULL
was	NULL
treated	NULL
with	NULL
20	NULL
units/ml	NULL
micrococcal	NULL
nuclease	NULL
and	NULL
10	NULL
ug/ml	NULL
RNase	NULL
A	NULL
,	NULL
then	NULL
purified	NULL
by	NULL
successive	NULL
steps	NULL
of	NULL
DEAE	NULL
chromatography	NULL
,	NULL
amylose	NULL
resin	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
affinity	NULL
chromatography	NULL
,	NULL
and	NULL
ion	NULL
exchange	NULL
chromatography	NULL
on	NULL
Mono	NULL
S.	NULL
New	NULL
Zealand	NULL
White	NULL
rabbits	NULL
were	NULL
hyperimmunized	NULL
with	NULL
purified	NULL
and	NULL
denatured	NULL
protein	NULL
(	NULL
100	NULL
ug/injection	NULL
)	NULL
,	NULL
and	NULL
serum	NULL
antibodies	NULL
were	NULL
purified	NULL
by	NULL
ammonium	NULL
sulfate	NULL
precipitation	NULL
followed	NULL
by	NULL
affinity	NULL
chromatography	NULL
on	NULL
Hi-Trap	NULL
protein	NULL
A	NULL
Sepharose	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
and	NULL
concentrated	NULL
on	NULL
Centricon	NULL
(	NULL
Amicon	NULL
)	NULL
.	NULL

Immunofluorescent	NULL
staining	NULL
and	NULL
immunoblotting	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
by	NULL
Li	NULL
et	NULL
al	NULL
.	NULL

(	NULL
34	NULL
)	NULL
using	NULL
anti-nucleolin	NULL
antiserum	NULL
at	NULL
1:50	NULL
dilution	NULL
.	NULL

The	NULL
mAb	NULL
12CA5	NULL
,	NULL
specific	NULL
for	NULL
the	NULL
HA	NULL
epitope	NULL
was	NULL
prepared	NULL
as	NULL
high	NULL
titer	NULL
ascites	NULL
fluid	NULL
.	NULL

DNA	NULL
Mobility-Shift	NULL
Analysis	NULL
.	NULL

Binding	NULL
to	NULL
a	NULL
synthetic	NULL
duplex	NULL
oligonucleotide	NULL
carrying	NULL
the	NULL
LR1	NULL
§y1	NULL
site	NULL
was	NULL
assayed	NULL
by	NULL
DNA	NULL
mobility-shift	NULL
,	NULL
as	NULL
described	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Assays	NULL
of	NULL
crude	NULL
nuclear	NULL
extract	NULL
contained	NULL
1	NULL
ug	NULL
of	NULL
protein	NULL
per	NULL
lane	NULL
,	NULL
and	NULL
assays	NULL
of	NULL
purified	NULL
LR1	NULL
contained	NULL
~1	NULL
ng	NULL
protein	NULL
per	NULL
lane	NULL
.	NULL

Gel	NULL
shift	NULL
assays	NULL
used	NULL
from	NULL
0-2	NULL
ug	NULL
of	NULL
purified	NULL
rabbit	NULL
serum	NULL
antibodies	NULL
or	NULL
1	NULL
ul	NULL
12CAS	NULL
ascites	NULL
fluid	NULL
.	NULL

Quantification	NULL
of	NULL
band	NULL
intensity	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
a	NULL
Bio-Rad	NULL
PhosphorImager	NULL
.	NULL

RESULTS	NULL
Microsequence	NULL
Analysis	NULL
Shows	NULL
the	NULL
106-kDa	NULL
Component	NULL
of	NULL
LR1	NULL
to	NULL
be	NULL
Nucleolin	NULL
,	NULL
a	NULL
709-aa	NULL
Polypeptide	NULL
.	NULL

The	NULL
106-kDa	NULL
band	NULL
in	NULL
the	NULL
preparation	NULL
of	NULL
LR1	NULL
purified	NULL
from	NULL
Raji	NULL
cells	NULL
was	NULL
digested	NULL
with	NULL
endoprotease	NULL
lys	NULL
C	NULL
,	NULL
and	NULL
two	NULL
sequenced	NULL
peptides	NULL
were	NULL
found	NULL
to	NULL
be	NULL
identical	NULL
to	NULL
predicted	NULL
lysyl	NULL
peptides	NULL
of	NULL
human	NULL
nucleolin	NULL
(	NULL
22	NULL
)	NULL
,	NULL
peptide	NULL
1	NULL
to	NULL
residues	NULL
523-536	NULL
and	NULL
peptide	NULL
2	NULL
to	NULL
residues	NULL
610-623	NULL
.	NULL

LR1-DNA	NULL
binding	NULL
activity	NULL
is	NULL
B	NULL
cell	NULL
specific	NULL
.	NULL

To	NULL
ask	NULL
if	NULL
there	NULL
might	NULL
be	NULL
a	NULL
B	NULL
cell-specific	NULL
form	NULL
of	NULL
nucleolin	NULL
,	NULL
we	NULL
isolated	NULL
and	NULL
sequenced	NULL
9	NULL
B	NULL
cell	NULL
nucleolin	NULL
cDNAs	NULL
.	NULL

These	NULL
clones	NULL
all	NULL
carried	NULL
9	NULL
nucleotide	NULL
not	NULL
present	NULL
in	NULL
the	NULL
published	NULL
sequence	NULL
of	NULL
nucleolin	NULL
from	NULL
a	NULL
human	NULL
retinal	NULL
cDNA	NULL
library	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Rese-quencing	NULL
the	NULL
human	NULL
retinal	NULL
nucleolin	NULL
cDNA	NULL
clone	NULL
(	NULL
22	NULL
)	NULL
showed	NULL
that	NULL
a	NULL
small	NULL
region	NULL
,	NULL
encoding	NULL
amino	NULL
acid	NULL
residues	NULL
624-626	NULL
,	NULL
had	NULL
been	NULL
omitted	NULL
from	NULL
the	NULL
published	NULL
sequence	NULL
.	NULL

The	NULL
corrected	NULL
sequence	NULL
of	NULL
the	NULL
predicted	NULL
human	NULL
nucleolin	NULL
polypeptide	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
and	NULL
the	NULL
corresponding	NULL
domains	NULL
of	NULL
the	NULL
nucleolin	NULL
polypeptide	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
.	NULL

We	NULL
found	NULL
no	NULL
evidence	NULL
for	NULL
B	NULL
cell-specific	NULL
,	NULL
alternatively	NULL
spliced	NULL
forms	NULL
of	NULL
nucleolin	NULL
.	NULL

Nucleolin	NULL
is	NULL
an	NULL
abundant	NULL
protein	NULL
,	NULL
and	NULL
it	NULL
was	NULL
possible	NULL
that	NULL
it	NULL
might	NULL
have	NULL
copurified	NULL
as	NULL
a	NULL
contaminant	NULL
in	NULL
the	NULL
LR1	NULL
prepara-tion	NULL
.	NULL

The	NULL
oligonucleotide	NULL
affinity	NULL
chromatography	NULL
step	NULL
is	NULL
of	NULL
particular	NULL
concern	NULL
because	NULL
others	NULL
have	NULL
observed	NULL
nucleolin	NULL
or	NULL
nucleolin	NULL
fragments	NULL
in	NULL
protein	NULL
preparations	NULL
purified	NULL
by	NULL
affinity	NULL
chromatography	NULL
using	NULL
G-rich	NULL
telomeric	NULL
DNA	NULL
sequences	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Another	NULL
preparation	NULL
of	NULL
LR1	NULL
was	NULL
generated	NULL
,	NULL
from	NULL
a	NULL
murine	NULL
pre-B	NULL
cell	NULL
line	NULL
,	NULL
purified	NULL
12,000-fold	NULL
by	NULL
four	NULL
steps	NULL
of	NULL
column	NULL
chromatography	NULL
and	NULL
demonstrated	NULL
to	NULL
contain	NULL
nucleolin	NULL
by	NULL
Biochemistry	NULL
:	NULL
Hanakahi	NULL
et	NULL
al	NULL
.	NULL

106	NULL
kD	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Specificity	NULL
of	NULL
antinucleolin	NULL
antibodies	NULL
.	NULL

(	NULL
4	NULL
)	NULL
In	NULL
situ	NULL
immunofluorescent	NULL
staining	NULL
of	NULL
PD31	NULL
murine	NULL
pre-B	NULL
cells	NULL
with	NULL
antinucleolin	NULL
antibodies	NULL
.	NULL

Arrows	NULL
indicate	NULL
two	NULL
of	NULL
the	NULL
nucleoli	NULL
evident	NULL
by	NULL
staining	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Immunoblot	NULL
analysis	NULL
of	NULL
crude	NULL
PD31	NULL
nuclear	NULL
extract	NULL
;	NULL
the	NULL
single	NULL
band	NULL
at	NULL
106	NULL
kDa	NULL
is	NULL
indicated	NULL
.	NULL

immunoblotting	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Both	NULL
the	NULL
degree	NULL
of	NULL
purification	NULL
and	NULL
the	NULL
relatively	NULL
high	NULL
salt	NULL
used	NULL
in	NULL
chromato-graphic	NULL
elution	NULL
steps	NULL
made	NULL
it	NULL
unlikely	NULL
that	NULL
nucleolin	NULL
was	NULL
a	NULL
contaminant	NULL
or	NULL
was	NULL
only	NULL
weakly	NULL
associated	NULL
with	NULL
the	NULL
binding	NULL
complex	NULL
.	NULL

We	NULL
therefore	NULL
set	NULL
about	NULL
to	NULL
demonstrate	NULL
as	NULL
rigorously	NULL
as	NULL
possible	NULL
that	NULL
nucleolin	NULL
is	NULL
indeed	NULL
a	NULL
component	NULL
of	NULL
the	NULL
LR1-DNA	NULL
binding	NULL
complex	NULL
.	NULL

Recognition	NULL
of	NULL
LR1	NULL
by	NULL
Polyclonal	NULL
Antinucleolin	NULL
Antibodies	NULL
Generates	NULL
a	NULL
``	NULL
Subshifted	NULL
``	NULL
Complex	NULL
in	NULL
Native	NULL
Gels	NULL
.	NULL

We	NULL
raised	NULL
rabbit	NULL
polyclonal	NULL
antibodies	NULL
against	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
recombinant	NULL
human	NULL
nucleolin	NULL
(	NULL
residues	NULL
284-709	NULL
)	NULL
.	NULL

As	NULL
anti-DNA	NULL
antibodies	NULL
in	NULL
the	NULL
serum	NULL
would	NULL
interfere	NULL
with	NULL
gel	NULL
mobility-shift	NULL
assays	NULL
of	NULL
LR1	NULL
activity	NULL
,	NULL
the	NULL
protein	NULL
used	NULL
for	NULL
immunization	NULL
was	NULL
purified	NULL
to	NULL
homogeneity	NULL
from	NULL
nuclease-treated	NULL
cell	NULL
extract	NULL
.	NULL

The	NULL
antibodies	NULL
,	NULL
purified	NULL
by	NULL
protein	NULL
A	NULL
affinity	NULL
chromatography	NULL
,	NULL
specifically	NULL
recognized	NULL
nucleoli	NULL
in	NULL
immunofluorescent	NULL
staining	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

They	NULL
also	NULL
specifically	NULL
recognized	NULL
the	NULL
106-kDa	NULL
nucleolin	NULL
polypeptide	NULL
in	NULL
PD31	NULL
cell	NULL
nuclear	NULL
extract	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
immunoblotting	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Recognition	NULL
of	NULL
LR1I-DNA	NULL
binding	NULL
activity	NULL
by	NULL
the	NULL
antinucleolin	NULL
antibodies	NULL
was	NULL
tested	NULL
by	NULL
gel	NULL
mobility-shift	NULL
.	NULL

Interaction	NULL
of	NULL
antibodies	NULL
with	NULL
a	NULL
DNA	NULL
binding	NULL
protein	NULL
typically	NULL
has	NULL
one	NULL
of	NULL
two	NULL
effects	NULL
on	NULL
formation	NULL
of	NULL
a	NULL
protein-DNA	NULL
complex	NULL
:	NULL
the	NULL
antibodies	NULL
may	NULL
inhibit	NULL
binding	NULL
,	NULL
in	NULL
which	NULL
case	NULL
no	NULL
shifted	NULL
band	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
3607	NULL
is	NULL
evident	NULL
;	NULL
or	NULL
the	NULL
antibodies	NULL
may	NULL
further	NULL
retard	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
protein-DNA	NULL
complex	NULL
,	NULL
producing	NULL
a	NULL
highly	NULL
retarded	NULL
band	NULL
referred	NULL
to	NULL
as	NULL
a	NULL
supershift	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
treatment	NULL
of	NULL
LR1	NULL
with	NULL
the	NULL
anti-nucleolin	NULL
antibodies	NULL
neither	NULL
inhibited	NULL
binding	NULL
nor	NULL
caused	NULL
a	NULL
supershift	NULL
.	NULL

Instead	NULL
,	NULL
the	NULL
antibodies	NULL
increased	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
LR1-DNA	NULL
complex	NULL
,	NULL
producing	NULL
a	NULL
``	NULL
sub-shift	NULL
.	NULL
``	NULL

Both	NULL
crude	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
and	NULL
highly	NULL
purified	NULL
LR1	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
treated	NULL
with	NULL
the	NULL
anti-nucleolin	NULL
antibodies	NULL
displayed	NULL
an	NULL
identical	NULL
subshift	NULL
,	NULL
while	NULL
antibodies	NULL
from	NULL
pre-immune	NULL
serum	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
complex	NULL
mobility	NULL
.	NULL

Several	NULL
trivial	NULL
explanations	NULL
for	NULL
the	NULL
subshift	NULL
can	NULL
be	NULL
ruled	NULL
out	NULL
.	NULL

The	NULL
subshift	NULL
can	NULL
not	NULL
be	NULL
accounted	NULL
for	NULL
by	NULL
anti-DNA	NULL
activity	NULL
of	NULL
the	NULL
antibodies	NULL
,	NULL
because	NULL
migration	NULL
of	NULL
the	NULL
labeled	NULL
DNA	NULL
duplex	NULL
was	NULL
not	NULL
altered	NULL
by	NULL
incubation	NULL
with	NULL
the	NULL
antibodies	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
LR1	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
Right	NULL
)	NULL
.	NULL

The	NULL
subshift	NULL
is	NULL
unlikely	NULL
to	NULL
result	NULL
from	NULL
proteolysis	NULL
,	NULL
as	NULL
the	NULL
antibodies	NULL
had	NULL
been	NULL
affinity	NULL
purified	NULL
on	NULL
protein	NULL
A	NULL
,	NULL
which	NULL
should	NULL
remove	NULL
contaminating	NULL
proteases	NULL
;	NULL
and	NULL
antibodies	NULL
from	NULL
pre-immune	NULL
serum	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
complex	NULL
mobility	NULL
either	NULL
in	NULL
crude	NULL
extract	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
or	NULL
highly	NULL
purified	NULL
protein	NULL
preparations	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
;	NULL
and	NULL
the	NULL
antinucleolin	NULL
antibodies	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
other	NULL
protein-DNA	NULL
interactions	NULL
,	NULL
including	NULL
those	NULL
of	NULL
Sp1	NULL
and	NULL
Ku	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
subshift	NULL
is	NULL
not	NULL
peculiar	NULL
to	NULL
a	NULL
single	NULL
antibody	NULL
preparation	NULL
,	NULL
as	NULL
serum	NULL
from	NULL
two	NULL
different	NULL
hyperimmunized	NULL
rabbits	NULL
produced	NULL
a	NULL
similar	NULL
subshift	NULL
.	NULL

One	NULL
explanation	NULL
for	NULL
the	NULL
subshift	NULL
could	NULL
be	NULL
that	NULL
interaction	NULL
with	NULL
antibodies	NULL
alters	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
binding	NULL
complex	NULL
to	NULL
make	NULL
it	NULL
migrate	NULL
faster	NULL
.	NULL

If	NULL
so	NULL
,	NULL
there	NULL
would	NULL
be	NULL
rabbit	NULL
antibodies	NULL
in	NULL
the	NULL
subshifted	NULL
complex	NULL
,	NULL
and	NULL
addition	NULL
of	NULL
anti-rabbit	NULL
Ig	NULL
to	NULL
the	NULL
binding	NULL
complex	NULL
should	NULL
further	NULL
alter	NULL
complex	NULL
mobility	NULL
.	NULL

We	NULL
tested	NULL
this	NULL
possibility	NULL
by	NULL
treating	NULL
purified	NULL
LR1	NULL
with	NULL
rabbit	NULL
antinucleolin	NULL
antibodies	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-rabbit	NULL
Ig	NULL
.	NULL

We	NULL
tested	NULL
both	NULL
anti-rabbit	NULL
IgM	NULL
and	NULL
anti-rabbit-Ig	NULL
(	NULL
all	NULL
isotypes	NULL
)	NULL
,	NULL
in	NULL
reactions	NULL
that	NULL
contained	NULL
1	NULL
or	NULL
5	NULL
ug	NULL
of	NULL
affinity-purified	NULL
antirabbit	NULL
Ig	NULL
and	NULL
2	NULL
ug	NULL
of	NULL
serum	NULL
antibodies	NULL
from	NULL
a	NULL
rabbit	NULL
immunized	NULL
with	NULL
recombinant	NULL
nucleolin	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
even	NULL
at	NULL
2.5-fold	NULL
excess	NULL
over	NULL
rabbit	NULL
serum	NULL
antibodies	NULL
,	NULL
the	NULL
anti-rabbit	NULL
IgM	NULL
or	NULL
IgG	NULL
antibodies	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
subshift	NULL
.	NULL

The	NULL
most	NULL
likely	NULL
explanation	NULL
for	NULL
the	NULL
subshift	NULL
therefore	NULL
appears	NULL
to	NULL
be	NULL
that	NULL
the	NULL
antinucleolin	NULL
antibodies	NULL
remove	NULL
nucleolin	NULL
from	NULL
the	NULL
DNA	NULL
binding	NULL
complex	NULL
,	NULL
leaving	NULL
the	NULL
remainder	NULL
of	NULL
the	NULL
complex	NULL
in	NULL
contact	NULL
with	NULL
the	NULL
DNA	NULL
.	NULL

Sadowski	NULL
et	NULL
al	NULL
.	NULL

(	NULL
36	NULL
)	NULL
previously	NULL
observed	NULL
a	NULL
subshift	NULL
upon	NULL
treatment	NULL
of	NULL
the	NULL
small	NULL
o	NULL
6	NULL
o	NULL
s	NULL
$	NULL
-	NULL
oerligM	NULL
o-rl	NULL
Ye	NULL
&	NULL
¥	NULL
re	NULL
P	NULL
-	NULL
Rd	NULL
9	NULL
A	NULL
.	NULL

B.	NULL
s*	NULL
``	NULL
s	NULL
ems-	NULL
g/	NULL
C.	NULL
A*	NULL
2A	NULL
2	NULL
a-nuc	NULL
$	NULL
-	NULL
=-	NULL
-	NULL
4	NULL
4	NULL
4+	NULL
4	NULL
+	NULL
LRT	NULL
=	NULL
-	NULL
-~	NULL
+	NULL
+	NULL
+	NULL
+	NULL
++	NULL
LR1	NULL
~	NULL
>	NULL
be	NULL
l	NULL
>	NULL
Min	NULL
LR1	NULL
--	NULL
a	NULL
subshift	NULL
i	NULL
subshift	NULL
%	NULL
CO8	NULL
subshift	NULL
tree	NULL
a	NULL
``	NULL
?	NULL

a	NULL
``	NULL
?	NULL

duplex	NULL
uplex	NULL
P	NULL
``	NULL
``	NULL
*	NULL
thaa	NULL
!	NULL

``	NULL
4	NULL
.	NULL

tail	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

-	NULL
Gel	NULL
mobility-shift	NULL
analysis	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
antinucleolin	NULL
antibodies	NULL
on	NULL
LR1-DNA	NULL
binding	NULL
activity	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Nuclear	NULL
extract	NULL
from	NULL
PD31	NULL
pre-B	NULL
cells	NULL
was	NULL
treated	NULL
with	NULL
no	NULL
antibodies	NULL
(	NULL
no	NULL
Ab	NULL
)	NULL
or	NULL
2	NULL
ug	NULL
of	NULL
protein	NULL
A-purified	NULL
antibodies	NULL
from	NULL
pre-immune	NULL
serum	NULL
(	NULL
pre	NULL
)	NULL
or	NULL
from	NULL
a	NULL
rabbit	NULL
immunized	NULL
with	NULL
recombinant	NULL
human	NULL
nucleolin	NULL
(	NULL
a-nuc	NULL
)	NULL
.	NULL

Arrows	NULL
indicate	NULL
bands	NULL
corresponding	NULL
to	NULL
the	NULL
LR1-DNA	NULL
complex	NULL
(	NULL
LR1	NULL
)	NULL
,	NULL
the	NULL
subshift	NULL
,	NULL
and	NULL
free	NULL
DNA	NULL
duplex	NULL
.	NULL

(	NULL
B	NULL
)	NULL
LR1	NULL
purified	NULL
12,000-fold	NULL
from	NULL
PD31	NULL
pre-B	NULL
cells	NULL
was	NULL
treated	NULL
with	NULL
0	NULL
,	NULL
0.016	NULL
,	NULL
0.08	NULL
,	NULL
0.4	NULL
or	NULL
2	NULL
ug	NULL
of	NULL
protein	NULL
A	NULL
purified	NULL
antibodies	NULL
from	NULL
pre-immune	NULL
serum	NULL
(	NULL
pre	NULL
)	NULL
or	NULL
from	NULL
a	NULL
rabbit	NULL
immunized	NULL
with	NULL
recombinant	NULL
human	NULL
nucleolin	NULL
(	NULL
«	NULL
-nuc	NULL
)	NULL
.	NULL

Control	NULL
lanes	NULL
on	NULL
the	NULL
right	NULL
show	NULL
that	NULL
neither	NULL
antibody	NULL
preparation	NULL
alone	NULL
altered	NULL
mobility	NULL
of	NULL
the	NULL
DNA	NULL
duplex	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Purified	NULL
LR1	NULL
was	NULL
treated	NULL
with	NULL
2	NULL
ug	NULL
rabbit	NULL
polyclonal	NULL
antinucleolin	NULL
antibodies	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
antirabbit	NULL
Ig	NULL
(	NULL
a-rlg	NULL
)	NULL
or	NULL
antirabbit	NULL
IgM	NULL
antibodies	NULL
(	NULL
«	NULL
-rIgM	NULL
)	NULL
at	NULL
1	NULL
or	NULL
5	NULL
ug/reaction	NULL
.	NULL

3608	NULL
Biochemistry	NULL
:	NULL
Hanakahi	NULL
et	NULL
al	NULL
.	NULL

nuclear	NULL
RNA	NULL
promoter	NULL
proximal	NULL
sequence	NULL
element	NULL
bound	NULL
to	NULL
a	NULL
complex	NULL
called	NULL
SNAP	NULL
,	NULL
with	NULL
anti-TATA-box	NULL
binding	NULL
protein	NULL
antibodies	NULL
,	NULL
which	NULL
they	NULL
interpreted	NULL
as	NULL
resulting	NULL
from	NULL
specific	NULL
depletion	NULL
of	NULL
one	NULL
component	NULL
from	NULL
the	NULL
binding	NULL
complex	NULL
.	NULL

Further	NULL
experiments	NULL
,	NULL
described	NULL
below	NULL
,	NULL
are	NULL
consistent	NULL
with	NULL
this	NULL
interpretation	NULL
of	NULL
the	NULL
LR1	NULL
subshift	NULL
.	NULL

Anti-Tag	NULL
Antibodies	NULL
Supershift	NULL
Epitope-Tagged	NULL
Nucleolin	NULL
in	NULL
the	NULL
LR1-DNA	NULL
Binding	NULL
Complex	NULL
.	NULL

The	NULL
sensitivity	NULL
to	NULL
antinucleolin	NULL
antibodies	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
shows	NULL
that	NULL
nucleolin	NULL
,	NULL
or	NULL
a	NULL
protein	NULL
that	NULL
shares	NULL
epitopes	NULL
with	NULL
nucleolin	NULL
,	NULL
is	NULL
present	NULL
in	NULL
the	NULL
LR1-DNA	NULL
binding	NULL
complex	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
polypeptide	NULL
recognized	NULL
by	NULL
the	NULL
antibodies	NULL
is	NULL
bona	NULL
fide	NULL
nucleolin	NULL
or	NULL
a	NULL
related	NULL
protein	NULL
,	NULL
we	NULL
transfected	NULL
the	NULL
murine	NULL
pre-B	NULL
cell	NULL
line	NULL
,	NULL
PD31	NULL
,	NULL
with	NULL
constructs	NULL
in	NULL
which	NULL
the	NULL
CMV	NULL
promoter	NULL
drives	NULL
expression	NULL
of	NULL
either	NULL
an	NULL
unmodified	NULL
nucleolin	NULL
cDNA	NULL
(	NULL
pNFor4	NULL
)	NULL
,	NULL
or	NULL
a	NULL
nucleolin	NULL
cDNA	NULL
carrying	NULL
an	NULL
HA	NULL
epitope	NULL
tag	NULL
at	NULL
the	NULL
amino	NULL
terminus	NULL
(	NULL
pNtag4	NULL
)	NULL
.	NULL

Extracts	NULL
were	NULL
assayed	NULL
for	NULL
LR1-DNA	NULL
binding	NULL
activity	NULL
by	NULL
gel	NULL
mobility-shift	NULL
.	NULL

Transfection	NULL
with	NULL
either	NULL
pNtagd4	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
or	NULL
pNFor4	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
4-fold	NULL
increase	NULL
in	NULL
LR1-DNA	NULL
binding	NULL
activity	NULL
.	NULL

Treatment	NULL
with	NULL
the	NULL
anti-tag	NULL
mAb	NULL
,	NULL
12CAS	NULL
,	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
mobility	NULL
of	NULL
shifted	NULL
bands	NULL
produced	NULL
by	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
untagged	NULL
construct	NULL
,	NULL
pNFor4	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
Left	NULL
)	NULL
,	NULL
but	NULL
when	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
pNtag4	NULL
were	NULL
incubated	NULL
with	NULL
this	NULL
antibody	NULL
prior	NULL
to	NULL
the	NULL
gel	NULL
shift	NULL
assay	NULL
,	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
protein-DNA	NULL
complex	NULL
was	NULL
retarded	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
Center	NULL
)	NULL
.	NULL

Only	NULL
a	NULL
fraction	NULL
of	NULL
the	NULL
complexed	NULL
DNA	NULL
was	NULL
super-shifted	NULL
,	NULL
presumably	NULL
because	NULL
the	NULL
tagged	NULL
construct	NULL
encodes	NULL
only	NULL
a	NULL
fraction	NULL
of	NULL
the	NULL
nucleolin	NULL
in	NULL
the	NULL
LR1-DNA	NULL
complex	NULL
.	NULL

Sur-prisingly	NULL
,	NULL
treatment	NULL
of	NULL
HA-tagged	NULL
LR1	NULL
with	NULL
the	NULL
anti-tag	NULL
monoclonal	NULL
results	NULL
in	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
DNA	NULL
bound	NULL
by	NULL
the	NULL
protein	NULL
.	NULL

This	NULL
is	NULL
a	NULL
reproducible	NULL
effect	NULL
of	NULL
treating	NULL
tagged	NULL
LR1	NULL
with	NULL
the	NULL
12CAS	NULL
mAb	NULL
.	NULL

One	NULL
possible	NULL
explanation	NULL
is	NULL
that	NULL
interaction	NULL
with	NULL
the	NULL
antibody	NULL
increases	NULL
affinity	NULL
of	NULL
LR1	NULL
for	NULL
DNA	NULL
.	NULL

Control	NULL
lanes	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
Right	NULL
)	NULL
show	NULL
that	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
nuclear	NULL
extract	NULL
,	NULL
the	NULL
anti-tag	NULL
antibody	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
free	NULL
labeled	NULL
DNA	NULL
duplex	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
LR1-DNA	NULL
binding	NULL
activity	NULL
contains	NULL
bona	NULL
fide	NULL
nucleolin	NULL
.	NULL

A	NULL
.	NULL

B	NULL
transfected	NULL
pNtagé	NULL
12cas	NULL
.	NULL

_	NULL
<	NULL
]	NULL
.	NULL

«	NULL
_	NULL
..	NULL
DNA	NULL
20	NULL
ame	NULL
``	NULL
)	NULL
extract	NULL
.	NULL

PD3WpNFor4	NULL
PD31/pNtag4	NULL
_none	NULL
:	NULL
:	NULL
-	NULL
>	NULL
|	NULL
e	NULL
»	NULL
@	NULL
p	NULL
@	NULL
pep	NULL
)	NULL
'	NULL
LEI—b	NULL
“	NULL
...	NULL
free	NULL
duplex	NULL
-	NULL
»	NULL
free	NULL
duplex	NULL
-	NULL
#	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Epitope-tagged	NULL
nucleolin	NULL
is	NULL
found	NULL
in	NULL
the	NULL
LR1-DNA	NULL
binding	NULL
complex	NULL
.	NULL

PD31	NULL
pre-B	NULL
cells	NULL
were	NULL
mock-transfected	NULL
(	NULL
-	NULL
)	NULL
or	NULL
transfected	NULL
with	NULL
the	NULL
constructs	NULL
indicated	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Gel	NULL
mobility-shift	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
of	NULL
PD31	NULL
pre-B	NULL
cells	NULL
transfected	NULL
with	NULL
increasing	NULL
amounts	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
or	NULL
16	NULL
ug	NULL
)	NULL
of	NULL
pNtag4	NULL
,	NULL
which	NULL
expresses	NULL
nucleolin	NULL
cDNA	NULL
carrying	NULL
an	NULL
N-terminal	NULL
HA	NULL
tag	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Gel	NULL
mobility-shift	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
4	NULL
ug	NULL
pNtagd4	NULL
,	NULL
which	NULL
expresses	NULL
nucleolin	NULL
cDNA	NULL
carrying	NULL
an	NULL
N-terminal	NULL
HA	NULL
tag	NULL
;	NULL
or	NULL
4	NULL
ug	NULL
pNford4	NULL
,	NULL
which	NULL
expresses	NULL
untagged	NULL
nucleolin	NULL
cDNA	NULL
.	NULL

Reactions	NULL
were	NULL
treated	NULL
with	NULL
0.3	NULL
or	NULL
1	NULL
pl	NULL
of	NULL
anti-tag	NULL
mAb	NULL
12CA5	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Control	NULL
lanes	NULL
on	NULL
the	NULL
right	NULL
show	NULL
that	NULL
the	NULL
12CAS	NULL
antibody	NULL
preparation	NULL
alone	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
DNA	NULL
duplex	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
The	NULL
HA	NULL
epitope	NULL
encoded	NULL
by	NULL
pNtagd4	NULL
is	NULL
at	NULL
residue	NULL
4	NULL
of	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
nucleolin	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
anti-tag	NULL
antibodies	NULL
recognize	NULL
the	NULL
LR1-DNA	NULL
complex	NULL
suggests	NULL
that	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
nucleolin	NULL
is	NULL
exposed	NULL
in	NULL
this	NULL
complex	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
this	NULL
region	NULL
contains	NULL
long	NULL
acidic	NULL
stretches	NULL
,	NULL
including	NULL
repeats	NULL
of	NULL
glutamate	NULL
and	NULL
aspartate	NULL
up	NULL
to	NULL
38	NULL
residues	NULL
in	NULL
length	NULL
.	NULL

Conceivably	NULL
,	NULL
these	NULL
acidic	NULL
regions	NULL
within	NULL
the	NULL
N	NULL
terminus	NULL
might	NULL
function	NULL
as	NULL
``	NULL
acid	NULL
blobs	NULL
``	NULL
and	NULL
allow	NULL
LR1	NULL
to	NULL
activate	NULL
transcription	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
by	NULL
ionic	NULL
interactions	NULL
with	NULL
the	NULL
basal	NULL
transcription	NULL
apparatus	NULL
(	NULL
37	NULL
)	NULL
.	NULL

The	NULL
Presence	NULL
of	NULL
Nucleolin	NULL
in	NULL
the	NULL
LR1	NULL
Complex	NULL
Diminishes	NULL
Sequence	NULL
Specificity	NULL
of	NULL
DNA	NULL
Binding	NULL
.	NULL

The	NULL
experiments	NULL
described	NULL
above	NULL
identify	NULL
nucleolin	NULL
as	NULL
the	NULL
106-kDa	NULL
component	NULL
of	NULL
LR1	NULL
.	NULL

As	NULL
the	NULL
106-kDa	NULL
polypeptide	NULL
becomes	NULL
covalently	NULL
linked	NULL
to	NULL
DNA	NULL
upon	NULL
ultraviolet	NULL
crosslinking	NULL
(	NULL
2	NULL
,	NULL
16	NULL
)	NULL
,	NULL
nucleolin	NULL
appears	NULL
to	NULL
make	NULL
direct	NULL
contact	NULL
with	NULL
DNA	NULL
.	NULL

To	NULL
probe	NULL
the	NULL
role	NULL
of	NULL
nucleolin	NULL
in	NULL
LR1I-DNA	NULL
interaction	NULL
,	NULL
we	NULL
assayed	NULL
sequence-specificity	NULL
of	NULL
LR1	NULL
binding	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
antinucleolin	NULL
antibodies	NULL
.	NULL

Mutations	NULL
at	NULL
most	NULL
positions	NULL
in	NULL
the	NULL
LR1	NULL
site	NULL
,	NULL
CCTCCTGGTCAAGGCTGAA	NULL
,	NULL
do	NULL
not	NULL
affect	NULL
LR1	NULL
binding	NULL
,	NULL
but	NULL
mutation	NULL
of	NULL
either	NULL
of	NULL
the	NULL
two	NULL
underlined	NULL
G	NULL
residues	NULL
to	NULL
A	NULL
diminishes	NULL
binding	NULL
10-fold	NULL
or	NULL
more	NULL
(	NULL
ref	NULL
.	NULL

1	NULL
;	NULL
and	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

These	NULL
two	NULL
Gs	NULL
are	NULL
at	NULL
positions	NULL
8	NULL
and	NULL
14	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
.	NULL

By	NULL
replacing	NULL
the	NULL
underlined	NULL
G	NULL
residues	NULL
with	NULL
inosine	NULL
or	NULL
2-aminopurine	NULL
,	NULL
we	NULL
created	NULL
a	NULL
small	NULL
panel	NULL
of	NULL
synthetic	NULL
oligonucleotides	NULL
that	NULL
permitted	NULL
us	NULL
to	NULL
analyze	NULL
the	NULL
specificity	NULL
of	NULL
LR1-DNA	NULL
interactions	NULL
.	NULL

Inosine	NULL
differs	NULL
from	NULL
G	NULL
in	NULL
lacking	NULL
the	NULL
N	NULL
functional	NULL
group	NULL
in	NULL
the	NULL
minor	NULL
groove	NULL
,	NULL
and	NULL
2-aminopurine	NULL
differs	NULL
from	NULL
G	NULL
in	NULL
lacking	NULL
the	NULL
O	NULL
,	NULL
group	NULL
in	NULL
the	NULL
major	NULL
groove	NULL
.	NULL

Binding	NULL
of	NULL
the	NULL
LR1	NULL
complex	NULL
to	NULL
DNA	NULL
is	NULL
diminished	NULL
by	NULL
substitution	NULL
of	NULL
2-aminopurine	NULL
,	NULL
but	NULL
not	NULL
inosine	NULL
,	NULL
at	NULL
G8	NULL
;	NULL
and	NULL
by	NULL
substitution	NULL
of	NULL
inosine	NULL
but	NULL
not	NULL
2-aminopurine	NULL
at	NULL
G14	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
Leff	NULL
)	NULL
.	NULL

When	NULL
DNA	NULL
binding	NULL
was	NULL
assayed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-nucleolin	NULL
antibodies	NULL
,	NULL
binding	NULL
to	NULL
some	NULL
of	NULL
these	NULL
oligonucleotides	NULL
was	NULL
altered	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
Right	NULL
)	NULL
.	NULL

While	NULL
binding	NULL
to	NULL
substitutions	NULL
at	NULL
position	NULL
14	NULL
was	NULL
essentially	NULL
unchanged	NULL
,	NULL
binding	NULL
to	NULL
GSI	NULL
was	NULL
somewhat	NULL
reduced	NULL
,	NULL
and	NULL
binding	NULL
to	NULL
G8-2AP	NULL
was	NULL
considerably	NULL
reduced	NULL
.	NULL

Removal	NULL
of	NULL
nucleolin	NULL
from	NULL
the	NULL
binding	NULL
complex	NULL
therefore	NULL
renders	NULL
binding	NULL
more	NULL
sensitive	NULL
to	NULL
certain	NULL
substitutions	NULL
.	NULL

In	NULL
the	NULL
LR1	NULL
complex	NULL
,	NULL
nucleolin	NULL
may	NULL
relax	NULL
stringency	NULL
of	NULL
DNA	NULL
recognition	NULL
and	NULL
permit	NULL
LR1	NULL
to	NULL
bind	NULL
S	NULL
region	NULL
DNA	NULL
in	NULL
a	NULL
fashion	NULL
that	NULL
tolerates	NULL
a	NULL
greater	NULL
degree	NULL
of	NULL
sequence	NULL
heterogeneity	NULL
.	NULL

60°	NULL
;	NULL
u-nucleolin	NULL
antibodies	NULL
position	NULL
position	NULL
4	NULL
14	NULL
8	NULL
G	NULL
A	NULL
I|	NULL
2AP	NULL
G	NULL
A	NULL
|	NULL
2AP	NULL
G	NULL
G	NULL
A	NULL
I|	NULL
2APG	NULL
A	NULL
|	NULL
2AP	NULL
#	NULL
»	NULL
free	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Gel	NULL
mobility-shift	NULL
analysis	NULL
of	NULL
LR1	NULL
binding	NULL
to	NULL
sites	NULL
substituted	NULL
with	NULL
inosine	NULL
(	NULL
I	NULL
)	NULL
and	NULL
Z-aminopurine	NULL
(	NULL
2-AP	NULL
)	NULL
.	NULL

Binding	NULL
specificity	NULL
of	NULL
LR1	NULL
in	NULL
PD31	NULL
nuclear	NULL
extracts	NULL
is	NULL
compared	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Left	NULL
)	NULL
and	NULL
presence	NULL
(	NULL
Right	NULL
)	NULL
of	NULL
antinucleolin	NULL
antibodies	NULL
.	NULL

Biochemistry	NULL
:	NULL
Hanakahi	NULL
et	NULL
al	NULL
.	NULL

DISCUSSION	NULL
LR1	NULL
is	NULL
a	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
protein	NULL
which	NULL
regulates	NULL
transcription	NULL
in	NULL
mammalian	NULL
B	NULL
cells	NULL
and	NULL
is	NULL
likely	NULL
also	NULL
to	NULL
function	NULL
in	NULL
switch	NULL
recombination	NULL
(	NULL
1-4	NULL
)	NULL
.	NULL

LR1	NULL
contains	NULL
two	NULL
polypeptides	NULL
,	NULL
of	NULL
106	NULL
kDa	NULL
and	NULL
45	NULL
kDa	NULL
.	NULL

The	NULL
106-kDa	NULL
component	NULL
of	NULL
LR1	NULL
is	NULL
nucleolin	NULL
.	NULL

What	NULL
is	NULL
the	NULL
role	NULL
of	NULL
nucleolin	NULL
in	NULL
LR1-DNA	NULL
binding	NULL
?	NULL

The	NULL
106-kDa	NULL
nucleolin	NULL
polypeptide	NULL
in	NULL
the	NULL
LR1	NULL
complex	NULL
contacts	NULL
DNA	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
ultraviolet	NULL
crosslinking	NULL
(	NULL
1	NULL
,	NULL
16	NULL
)	NULL
.	NULL

Nucleolin	NULL
also	NULL
affects	NULL
sequence-specificity	NULL
of	NULL
DNA	NULL
recognition	NULL
,	NULL
rendering	NULL
binding	NULL
less	NULL
sensitive	NULL
to	NULL
certain	NULL
substitutions	NULL
.	NULL

The	NULL
Ig	NULL
S	NULL
regions	NULL
are	NULL
composed	NULL
of	NULL
repetitive	NULL
,	NULL
G-rich	NULL
sequences	NULL
which	NULL
conform	NULL
to	NULL
a	NULL
loose	NULL
consensus	NULL
.	NULL

One	NULL
function	NULL
of	NULL
nucleolin	NULL
in	NULL
LR1-DNA	NULL
recognition	NULL
may	NULL
be	NULL
to	NULL
permit	NULL
LR1	NULL
to	NULL
bind	NULL
a	NULL
greater	NULL
variety	NULL
and	NULL
number	NULL
of	NULL
sequences	NULL
within	NULL
the	NULL
S	NULL
regions	NULL
.	NULL

Two	NULL
results	NULL
argue	NULL
that	NULL
nucleolin	NULL
alone	NULL
is	NULL
not	NULL
responsible	NULL
for	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
by	NULL
LR1	NULL
.	NULL

First	NULL
,	NULL
treatment	NULL
of	NULL
LR1	NULL
with	NULL
antinucleolin	NULL
antibodies	NULL
depletes	NULL
nucleolin	NULL
from	NULL
the	NULL
complex	NULL
without	NULL
diminishing	NULL
DNA	NULL
binding	NULL
.	NULL

Second	NULL
,	NULL
while	NULL
a	NULL
recombinant	NULL
fusion	NULL
protein	NULL
expressing	NULL
the	NULL
C-terminal	NULL
RRM	NULL
and	NULL
RGG	NULL
domains	NULL
of	NULL
nucleolin	NULL
can	NULL
bind	NULL
to	NULL
duplex	NULL
DNA	NULL
carrying	NULL
an	NULL
LR1	NULL
site	NULL
,	NULL
binding	NULL
is	NULL
reduced	NULL
by	NULL
three	NULL
orders	NULL
of	NULL
magnitude	NULL
and	NULL
does	NULL
not	NULL
exhibit	NULL
the	NULL
sequence-specificity	NULL
characteristic	NULL
of	NULL
the	NULL
LR1	NULL
complex	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Others	NULL
have	NULL
identified	NULL
nucleolin	NULL
as	NULL
a	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
protein	NULL
(	NULL
38	NULL
,	NULL
39	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
our	NULL
experiments	NULL
,	NULL
these	NULL
reports	NULL
were	NULL
based	NULL
only	NULL
upon	NULL
microsequence	NULL
analysis	NULL
of	NULL
purified	NULL
protein	NULL
and	NULL
were	NULL
not	NULL
supported	NULL
with	NULL
evidence	NULL
showing	NULL
that	NULL
antinucleolin	NULL
antibodies	NULL
recognized	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
under	NULL
investigation	NULL
.	NULL

As	NULL
nucleolin	NULL
is	NULL
a	NULL
very	NULL
abundant	NULL
protein	NULL
,	NULL
which	NULL
could	NULL
readily	NULL
copurify	NULL
as	NULL
a	NULL
contaminant	NULL
,	NULL
the	NULL
significance	NULL
of	NULL
these	NULL
reports	NULL
is	NULL
not	NULL
clear	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
that	NULL
recombinant	NULL
nucleolin	NULL
can	NULL
interact	NULL
with	NULL
long	NULL
subcloned	NULL
fragments	NULL
from	NULL
the	NULL
S	NULL
regions	NULL
(	NULL
40	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
these	NULL
experiments	NULL
DNA	NULL
binding	NULL
was	NULL
assayed	NULL
by	NULL
Southwestern	NULL
blotting	NULL
and	NULL
binding	NULL
affinity	NULL
was	NULL
not	NULL
reported	NULL
.	NULL

The	NULL
primary	NULL
sequence	NULL
and	NULL
predicted	NULL
structural	NULL
motifs	NULL
of	NULL
nucleolin	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
may	NULL
provide	NULL
clues	NULL
relevant	NULL
to	NULL
the	NULL
function	NULL
of	NULL
the	NULL
LR1	NULL
complex	NULL
in	NULL
transcription	NULL
and	NULL
in	NULL
recombination	NULL
.	NULL

The	NULL
N	NULL
terminus	NULL
of	NULL
nucleolin	NULL
contains	NULL
long	NULL
acidic	NULL
stretches	NULL
,	NULL
including	NULL
three	NULL
uninterrupted	NULL
runs	NULL
of	NULL
16	NULL
,	NULL
21	NULL
and	NULL
38	NULL
amino	NULL
acid	NULL
residues	NULL
,	NULL
which	NULL
could	NULL
function	NULL
as	NULL
``	NULL
acid	NULL
blobs	NULL
``	NULL
(	NULL
37	NULL
)	NULL
to	NULL
regulate	NULL
transcription	NULL
.	NULL

The	NULL
N	NULL
terminus	NULL
is	NULL
homologous	NULL
to	NULL
histone	NULL
H1	NULL
and	NULL
contains	NULL
nine	NULL
TPXKK	NULL
motifs	NULL
which	NULL
are	NULL
sites	NULL
for	NULL
phosphorylation	NULL
by	NULL
edc2	NULL
kinase	NULL
.	NULL

Mitosis-specific	NULL
phosphorylation	NULL
of	NULL
H1	NULL
at	NULL
these	NULL
sites	NULL
is	NULL
thought	NULL
to	NULL
facilitate	NULL
chromosome	NULL
condensation	NULL
;	NULL
and	NULL
in	NULL
the	NULL
nucleolus	NULL
,	NULL
nucleolin	NULL
is	NULL
thought	NULL
to	NULL
enhance	NULL
condensation	NULL
of	NULL
the	NULL
actively	NULL
transcribed	NULL
rDNA	NULL
at	NULL
mitosis	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Nucleolin	NULL
may	NULL
organize	NULL
the	NULL
structure	NULL
of	NULL
the	NULL
actively	NULL
transcribed	NULL
S	NULL
regions	NULL
in	NULL
an	NULL
analogous	NULL
fashion	NULL
,	NULL
responding	NULL
to	NULL
cell	NULL
cycle-specific	NULL
controls	NULL
before	NULL
,	NULL
during	NULL
or	NULL
after	NULL
recombination	NULL
.	NULL

The	NULL
central	NULL
region	NULL
of	NULL
nucleolin	NULL
is	NULL
composed	NULL
of	NULL
four	NULL
consensus	NULL
RRMs	NULL
(	NULL
or	NULL
RBDs	NULL
)	NULL
,	NULL
conserved	NULL
domains	NULL
of	NULL
90-100	NULL
amino	NULL
acids	NULL
that	NULL
form	NULL
B-sheet	NULL
structures	NULL
(	NULL
reviewed	NULL
in	NULL
refs	NULL
.	NULL

41	NULL
and	NULL
42	NULL
)	NULL
.	NULL

The	NULL
RRMs	NULL
are	NULL
thought	NULL
to	NULL
provide	NULL
a	NULL
platform	NULL
for	NULL
protein-RNA	NULL
contact	NULL
,	NULL
and	NULL
the	NULL
RNA	NULL
exposed	NULL
upon	NULL
this	NULL
platform	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
available	NULL
for	NULL
interaction	NULL
.	NULL

In	NULL
LR1	NULL
,	NULL
the	NULL
of	NULL
nucleolin	NULL
could	NULL
function	NULL
in	NULL
interaction	NULL
either	NULL
with	NULL
S	NULL
region	NULL
DNA	NULL
or	NULL
with	NULL
the	NULL
S	NULL
region	NULL
transcripts	NULL
that	NULL
are	NULL
essential	NULL
to	NULL
recombination	NULL
.	NULL

The	NULL
C	NULL
terminus	NULL
of	NULL
nucleolin	NULL
contains	NULL
RGG	NULL
motifs	NULL
,	NULL
also	NULL
common	NULL
in	NULL
RNA	NULL
binding	NULL
proteins	NULL
,	NULL
which	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
nucleolar	NULL
localization	NULL
(	NULL
32	NULL
,	NULL
43	NULL
)	NULL
,	NULL
RNA	NULL
binding	NULL
and	NULL
RNA	NULL
helix-destabilization	NULL
(	NULL
44	NULL
)	NULL
.	NULL

RGG	NULL
motifs	NULL
in	NULL
other	NULL
RRM-containing	NULL
proteins	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
facilitate	NULL
pro-tein-mediated	NULL
interactions	NULL
of	NULL
both	NULL
RNA	NULL
and	NULL
DNA	NULL
in	NULL
vitro	NULL
(	NULL
45-48	NULL
)	NULL
,	NULL
a	NULL
function	NULL
of	NULL
obvious	NULL
utility	NULL
in	NULL
a	NULL
polypeptide	NULL
component	NULL
of	NULL
a	NULL
complex	NULL
that	NULL
functions	NULL
in	NULL
recombination	NULL
.	NULL

In	NULL
LR1	NULL
,	NULL
protein-protein	NULL
interaction	NULL
mediated	NULL
by	NULL
the	NULL
C-terminal	NULL
regions	NULL
could	NULL
juxtapose	NULL
regions	NULL
of	NULL
DNA	NULL
bound	NULL
to	NULL
protein	NULL
.	NULL

Taken	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
3609	NULL
together	NULL
,	NULL
these	NULL
properties	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
picture	NULL
in	NULL
which	NULL
LR1	NULL
binds	NULL
to	NULL
multiple	NULL
sites	NULL
in	NULL
each	NULL
activated	NULL
S	NULL
region	NULL
,	NULL
and	NULL
functions	NULL
to	NULL
organize	NULL
S	NULL
region	NULL
DNA	NULL
for	NULL
transcription	NULL
,	NULL
recombination	NULL
,	NULL
or	NULL
both	NULL
.	NULL

LR1-DNA	NULL
binding	NULL
activity	NULL
is	NULL
B	NULL
cell-specific	NULL
,	NULL
but	NULL
nucleolin	NULL
is	NULL
ubiquitous	NULL
.	NULL

What	NULL
accounts	NULL
for	NULL
the	NULL
cell	NULL
type-specificity	NULL
of	NULL
LR1	NULL
activity	NULL
?	NULL

Alternative	NULL
processing	NULL
of	NULL
nucleolin	NULL
mRNA	NULL
could	NULL
in	NULL
principle	NULL
provide	NULL
a	NULL
mechanism	NULL
for	NULL
cell	NULL
type-specific	NULL
modification	NULL
of	NULL
nucleolin	NULL
,	NULL
but	NULL
we	NULL
have	NULL
not	NULL
found	NULL
evidence	NULL
of	NULL
alternative	NULL
processing	NULL
of	NULL
the	NULL
mRNA	NULL
.	NULL

Moreover	NULL
,	NULL
as	NULL
tagged	NULL
nucleolin	NULL
expressed	NULL
from	NULL
a	NULL
full-length	NULL
cDNA	NULL
clone	NULL
appears	NULL
in	NULL
the	NULL
LR1	NULL
shift	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
alternative	NULL
processing	NULL
of	NULL
nucleolin	NULL
is	NULL
key	NULL
to	NULL
producing	NULL
this	NULL
B	NULL
cell-specific	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

LR1I-DNA	NULL
binding	NULL
activity	NULL
is	NULL
dependent	NULL
on	NULL
phosphorylation	NULL
(	NULL
2	NULL
)	NULL
,	NULL
which	NULL
may	NULL
regulate	NULL
cell	NULL
type-specificity	NULL
.	NULL

Nucleolin	NULL
is	NULL
known	NULL
to	NULL
be	NULL
phosphorylated	NULL
,	NULL
N-glycosylated	NULL
,	NULL
and	NULL
to	NULL
contain	NULL
dimethylated	NULL
arginine	NULL
residues	NULL
in	NULL
the	NULL
C-terminal	NULL
RGGs	NULL
(	NULL
17-22	NULL
)	NULL
.	NULL

We	NULL
are	NULL
now	NULL
investigating	NULL
the	NULL
possibility	NULL
there	NULL
is	NULL
distinct	NULL
posttranslational	NULL
modification	NULL
of	NULL
the	NULL
nucleolin	NULL
in	NULL
the	NULL
LR1	NULL
complex	NULL
.	NULL

Switch	NULL
recombination	NULL
is	NULL
characteristic	NULL
of	NULL
the	NULL
mammalian	NULL
immune	NULL
response	NULL
,	NULL
and	NULL
it	NULL
has	NULL
not	NULL
been	NULL
observed	NULL
in	NULL
lower	NULL
vertebrates	NULL
.	NULL

This	NULL
raises	NULL
the	NULL
question	NULL
of	NULL
how	NULL
S	NULL
regions	NULL
and	NULL
switch	NULL
recombination	NULL
evolved	NULL
.	NULL

Sequence	NULL
homologies	NULL
have	NULL
been	NULL
reported	NULL
between	NULL
rDNA	NULL
and	NULL
regions	NULL
within	NULL
the	NULL
Ig	NULL
loci	NULL
(	NULL
25	NULL
)	NULL
,	NULL
which	NULL
may	NULL
reflect	NULL
a	NULL
common	NULL
origin	NULL
or	NULL
the	NULL
G-rich	NULL
base	NULL
composition	NULL
of	NULL
both	NULL
regions	NULL
.	NULL

There	NULL
is	NULL
also	NULL
functional	NULL
evidence	NULL
that	NULL
rDNA	NULL
sequences	NULL
can	NULL
play	NULL
special	NULL
roles	NULL
in	NULL
recombination	NULL
(	NULL
26-28	NULL
)	NULL
.	NULL

In	NULL
Saccharomyces	NULL
cerevisiae	NULL
,	NULL
the	NULL
HOT1	NULL
hotspot	NULL
for	NULL
mitotic	NULL
recombination	NULL
proved	NULL
to	NULL
be	NULL
identical	NULL
to	NULL
the	NULL
rDNA	NULL
promoter	NULL
(	NULL
26	NULL
)	NULL
.	NULL

In	NULL
Drosophila	NULL
,	NULL
active	NULL
rDNA	NULL
recombination	NULL
can	NULL
magnify	NULL
rDNA	NULL
repeats	NULL
in	NULL
somatic	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
,	NULL
and	NULL
during	NULL
meiosis	NULL
the	NULL
X	NULL
and	NULL
Y	NULL
chromosomes	NULL
pair	NULL
in	NULL
the	NULL
vicinity	NULL
of	NULL
the	NULL
nucleolus	NULL
organizer-the	NULL
rDNA	NULL
.	NULL

X	NULL
chromosomes	NULL
that	NULL
lack	NULL
the	NULL
pairing	NULL
region	NULL
segregate	NULL
randomly	NULL
,	NULL
but	NULL
this	NULL
can	NULL
be	NULL
corrected	NULL
by	NULL
P	NULL
element	NULL
insertion	NULL
of	NULL
an	NULL
rDNA	NULL
gene	NULL
into	NULL
heterochromatin	NULL
,	NULL
and	NULL
in	NULL
flies	NULL
carrying	NULL
such	NULL
insertions	NULL
,	NULL
X	NULL
chromosome	NULL
pairing	NULL
occurs	NULL
at	NULL
the	NULL
site	NULL
of	NULL
rDNA	NULL
insertion	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Our	NULL
demonstration	NULL
that	NULL
nucleolin	NULL
is	NULL
one	NULL
part	NULL
of	NULL
a	NULL
complex	NULL
that	NULL
interacts	NULL
with	NULL
S	NULL
regions	NULL
suggests	NULL
that	NULL
this	NULL
protein	NULL
may	NULL
have	NULL
followed	NULL
its	NULL
cognate	NULL
DNA	NULL
as	NULL
it	NULL
moved	NULL
from	NULL
one	NULL
function	NULL
to	NULL
another	NULL
.	NULL

The	NULL
G-rich	NULL
rDNAs	NULL
thus	NULL
provide	NULL
a	NULL
plausible	NULL
origin	NULL
for	NULL
the	NULL
evolution	NULL
of	NULL
Ig	NULL
S	NULL
regions	NULL
.	NULL

We	NULL
thank	NULL
D.	NULL
Gonda	NULL
,	NULL
W.	NULL
McGinnis	NULL
,	NULL
W.	NULL
Russ	NULL
,	NULL
J.	NULL
Sedivy	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Steitz	NULL
for	NULL
insightful	NULL
discussions	NULL
;	NULL
M.	NULL
Srivastava	NULL
for	NULL
a	NULL
human	NULL
nucleolin	NULL
cDNA	NULL
clone	NULL
;	NULL
and	NULL
J.	NULL
Flory	NULL
,	NULL
K.	NULL
Stone	NULL
,	NULL
and	NULL
K.	NULL
Williams	NULL
of	NULL
the	NULL
W.	NULL
M.	NULL
Keck	NULL
Foundation	NULL
for	NULL
oligonucleotide	NULL
synthesis	NULL
and	NULL
protein	NULL
sequence	NULL
analysis	NULL
.	NULL

LAH	NULL
.	NULL

was	NULL
the	NULL
recipient	NULL
of	NULL
Predoctoral	NULL
National	NULL
Research	NULL
Service	NULL
Award	NULL
1F31GHOO0118	NULL
,	NULL
L.	NULL
A.D	NULL
was	NULL
the	NULL
recipient	NULL
of	NULL
Postdoctoral	NULL
National	NULL
Research	NULL
Service	NULL
Award	NULL
5F32GM15948	NULL
,	NULL
and	NULL
this	NULL
research	NULL
was	NULL
supported	NULL
by	NULL
Grant	NULL
RO1	NULL
GM39799	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
and	NULL
Grant	NULL
PO1	NULL
CA16038	NULL
from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
.	NULL

1	NULL
.	NULL

Williams	NULL
,	NULL
M.	NULL
&	NULL
Maizels	NULL
,	NULL
N.	NULL
(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
2353-2361	NULL
.	NULL

2	NULL
.	NULL

Williams	NULL
,	NULL
M.	NULL
,	NULL
Hanakahi	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

&	NULL
Maizels	NULL
,	NULL
N.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
13731-13737	NULL
.	NULL

3	NULL
.	NULL

Brys	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Maizels	NULL
,	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91	NULL
,	NULL
4915-4919	NULL
.	NULL

4	NULL
.	NULL

Bulfone-Paus	NULL
,	NULL
S.	NULL
,	NULL
Dempsey	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

&	NULL
Maizels	NULL
,	NULL
N.	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
,	NULL
8293-8297	NULL
.	NULL

5	NULL
.	NULL

Mowatt	NULL
,	NULL
M.	NULL
R.	NULL
&	NULL
Dunnick	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

136	NULL
,	NULL
2674-2683	NULL
.	NULL

6	NULL
.	NULL

-	NULL
Nikaido	NULL
,	NULL
T.	NULL
,	NULL
Nakai	NULL
,	NULL
S.	NULL
&	NULL
Honjo	NULL
,	NULL
T.	NULL
(	NULL
1981	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
292	NULL
,	NULL
845-848	NULL
.	NULL

7	NULL
.	NULL

Petrini	NULL
,	NULL
J.	NULL
,	NULL
Shell	NULL
,	NULL
B.	NULL
,	NULL
Hummel	NULL
,	NULL
M.	NULL
&	NULL
Dunnick	NULL
,	NULL
W.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

138	NULL
,	NULL
1940-1946	NULL
.	NULL

8	NULL
.	NULL

Noelle	NULL
,	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
Immunity	NULL
4	NULL
,	NULL
415-419	NULL
.	NULL

9	NULL
.	NULL

Coffman	NULL
,	NULL
R.L	NULL
.	NULL

,	NULL
Lebman	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

&	NULL
Rothman	NULL
,	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
Adv	NULL
.	NULL

Immunol	NULL
.	NULL

54	NULL
,	NULL
229-270	NULL
.	NULL

10	NULL
.	NULL

Cogne	NULL
,	NULL
M.	NULL
,	NULL
Lansford	NULL
,	NULL
R.	NULL
,	NULL
Bottaro	NULL
,	NULL
A.	NULL
,	NULL
Zhang	NULL
,	NULL
J.	NULL
,	NULL
Gorman	NULL
,	NULL
J.	NULL
,	NULL
Young	NULL
,	NULL
F.	NULL
,	NULL
Cheng	NULL
,	NULL
H.	NULL
L.	NULL
&	NULL
Alt	NULL
,	NULL
F.	NULL
W.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
77	NULL
,	NULL
737-747	NULL
.	NULL

3610	NULL
11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

Biochemistry	NULL
:	NULL
Hanakahi	NULL
et	NULL
al	NULL
.	NULL

Gu	NULL
,	NULL
H.	NULL
,	NULL
Zou	NULL
,	NULL
R.-R.	NULL
&	NULL
Rajewsky	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
Cell	NULL
73	NULL
,	NULL
1155-1164	NULL
.	NULL

Jung	NULL
,	NULL
S.	NULL
,	NULL
Rajewsky	NULL
,	NULL
K.	NULL
&	NULL
Radbruch	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Science	NULL
259	NULL
,	NULL
984-987	NULL
.	NULL

Zhang	NULL
,	NULL
J.	NULL
,	NULL
Bottaro	NULL
,	NULL
A.	NULL
,	NULL
Li	NULL
,	NULL
S.	NULL
,	NULL
Steward	NULL
,	NULL
V.	NULL
&	NULL
Alt	NULL
,	NULL
F.	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
3529-3537	NULL
.	NULL

Xu	NULL
,	NULL
L.	NULL
,	NULL
Gorham	NULL
,	NULL
B.	NULL
,	NULL
Li	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Bottaro	NULL
,	NULL
A.	NULL
,	NULL
Alt	NULL
,	NULL
F.	NULL
W.	NULL
&	NULL
Rothman	NULL
,	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
3705-3709	NULL
.	NULL

Lorenz	NULL
,	NULL
M.	NULL
,	NULL
Jung	NULL
,	NULL
S.	NULL
&	NULL
Radbruch	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Science	NULL
267	NULL
,	NULL
1825-1828	NULL
.	NULL

Williams	NULL
,	NULL
M.	NULL
,	NULL
Brys	NULL
,	NULL
A.	NULL
,	NULL
Weiner	NULL
,	NULL
A.	NULL
M.	NULL
&	NULL
Maizels	NULL
,	NULL
N.	NULL
(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
4935-4936	NULL
.	NULL

Sollner-Webb	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Mougey	NULL
,	NULL
E.	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

16	NULL
,	NULL
58-62	NULL
.	NULL

Melese	NULL
,	NULL
T.	NULL
&	NULL
Xue	NULL
,	NULL
Z	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

7	NULL
,	NULL
319-324	NULL
.	NULL

Bourbon	NULL
,	NULL
H.-M.	NULL
&	NULL
Amalric	NULL
,	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
Gene	NULL
88	NULL
,	NULL
187-196	NULL
.	NULL

Bourbon	NULL
,	NULL
H.-M.	NULL
,	NULL
Lapeyre	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Amalric	NULL
,	NULL
F.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

200	NULL
,	NULL
627-638	NULL
.	NULL

Lapeyre	NULL
,	NULL
B.	NULL
,	NULL
Bourbon	NULL
,	NULL
H.	NULL
&	NULL
Amalric	NULL
,	NULL
F.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84	NULL
,	NULL
1472-1476	NULL
.	NULL

Srivastava	NULL
,	NULL
M.	NULL
,	NULL
Fleming	NULL
,	NULL
P.J	NULL
.	NULL

,	NULL
Pollard	NULL
,	NULL
H.	NULL
B	NULL
.	NULL

&	NULL
Bruns	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
FEBS	NULL
Leit	NULL
.	NULL

250	NULL
,	NULL
99-105	NULL
.	NULL

Peter	NULL
,	NULL
M.	NULL
,	NULL
Nakagawa	NULL
,	NULL
J.	NULL
,	NULL
Doree	NULL
,	NULL
M.	NULL
,	NULL
Labbe	NULL
,	NULL
J.	NULL
C.	NULL
&	NULL
Nigg	NULL
,	NULL
E.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
60	NULL
,	NULL
791-801	NULL
.	NULL

Belenguer	NULL
,	NULL
P.	NULL
,	NULL
Caizergues-Ferrer	NULL
,	NULL
M.	NULL
,	NULL
Labbe	NULL
,	NULL
J.-C.	NULL
,	NULL
Doree	NULL
,	NULL
M.	NULL
&	NULL
Amalric	NULL
,	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
3607-3617	NULL
.	NULL

Arnheim	NULL
,	NULL
N.	NULL
,	NULL
Seperack	NULL
,	NULL
P.	NULL
,	NULL
Banerji	NULL
,	NULL
J.	NULL
,	NULL
Lang	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
Micsfeld	NULL
,	NULL
R.	NULL
&	NULL
Marcu	NULL
,	NULL
K.	NULL
B	NULL
.	NULL

(	NULL
1980	NULL
)	NULL
Cell	NULL
22	NULL
,	NULL
179-85	NULL
.	NULL

Voelkel-Meiman	NULL
,	NULL
K.	NULL
,	NULL
Keil	NULL
,	NULL
R.	NULL
L.	NULL
&	NULL
Roeder	NULL
,	NULL
G.	NULL
S.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
48	NULL
,	NULL
1071-1079	NULL
.	NULL

Hawley	NULL
,	NULL
R.	NULL
S.	NULL
&	NULL
Tartof	NULL
,	NULL
K.	NULL
D.	NULL
(	NULL
1983	NULL
)	NULL
Genetics	NULL
104	NULL
,	NULL
63-80	NULL
.	NULL

McKee	NULL
,	NULL
B.	NULL
D.	NULL
&	NULL
Karpen	NULL
,	NULL
G.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
61	NULL
,	NULL
61-72	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
&	NULL
Roeder	NULL
,	NULL
R.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
.	NULL

Hagenbiichle	NULL
,	NULL
O	NULL
.	NULL

&	NULL
Wellauer	NULL
,	NULL
P.	NULL
K.	NULL
(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
3555-3559	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94	NULL
(	NULL
1997	NULL
)	NULL
Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Muller	NULL
,	NULL
M.	NULL
M.	NULL
&	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419-6420	NULL
.	NULL

Heine	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Rankin	NULL
,	NULL
M.	NULL
L.	NULL
&	NULL
DiMario	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
4	NULL
,	NULL
1189-1204	NULL
.	NULL

Li	NULL
,	NULL
M.-J	NULL
.	NULL

,	NULL
Leung	NULL
,	NULL
H.	NULL
&	NULL
Maizels	NULL
,	NULL
N.	NULL
(	NULL
1996	NULL
)	NULL
in	NULL
Methods	NULL
in	NULL
Molecular	NULL
Genetics	NULL
,	NULL
ed	NULL
.	NULL

Adolph	NULL
,	NULL
K.	NULL
W.	NULL
(	NULL
Academic	NULL
,	NULL
Orlando	NULL
,	NULL
FL	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

375-387	NULL
.	NULL

Li	NULL
,	NULL
M.-J	NULL
.	NULL

,	NULL
Peakman	NULL
,	NULL
M.-C.	NULL
,	NULL
Golub	NULL
,	NULL
E.	NULL
I.	NULL
,	NULL
Reddy	NULL
,	NULL
G.	NULL
,	NULL
Ward	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Radding	NULL
,	NULL
C.	NULL
M.	NULL
&	NULL
Maizels	NULL
,	NULL
N.	NULL
(	NULL
1996	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
,	NULL
10222-10227	NULL
.	NULL

Ishikawa	NULL
,	NULL
F.	NULL
,	NULL
Matunis	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Dreyfuss	NULL
,	NULL
G.	NULL
&	NULL
Cech	NULL
,	NULL
T.	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
4301-4310	NULL
.	NULL

Sadowski	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Henry	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
Lobo	NULL
,	NULL
S.	NULL
M.	NULL
&	NULL
Hernandez	NULL
,	NULL
N.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

1535-1548	NULL
.	NULL

Ptashne	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
335	NULL
,	NULL
683-689	NULL
.	NULL

Yang	NULL
,	NULL
T.	NULL
,	NULL
Tsai	NULL
,	NULL
W.	NULL
,	NULL
Lee	NULL
,	NULL
Y.	NULL
,	NULL
Lei	NULL
,	NULL
H.	NULL
,	NULL
Lai	NULL
,	NULL
M.	NULL
,	NULL
Chen	NULL
,	NULL
D.	NULL
,	NULL
Yeh	NULL
,	NULL
N.	NULL
&	NULL
Lee	NULL
,	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
6068-6974	NULL
.	NULL

Dickenson	NULL
,	NULL
L.	NULL
&	NULL
Kohwi-Shigematsu	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
456-465	NULL
.	NULL

Miranda	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
Chokler	NULL
,	NULL
I	NULL
.	NULL

&	NULL
Aguilera	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Exp	NULL
.	NULL

Cell	NULL
Res	NULL
.	NULL

217	NULL
,	NULL
294-308	NULL
.	NULL

Kenan	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Query	NULL
,	NULL
C.	NULL
C.	NULL
&	NULL
Keene	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

16	NULL
,	NULL
214-220	NULL
.	NULL

Burd	NULL
,	NULL
C.	NULL
G.	NULL
&	NULL
Dreyfuss	NULL
,	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
265	NULL
,	NULL
615-621	NULL
.	NULL

Schmidt-Zachmann	NULL
,	NULL
M.	NULL
S.	NULL
&	NULL
Nigg	NULL
,	NULL
E.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Science	NULL
105	NULL
,	NULL
799-806	NULL
.	NULL

Ghisolfi	NULL
,	NULL
L.	NULL
,	NULL
Joseph	NULL
,	NULL
G.	NULL
,	NULL
Amairic	NULL
,	NULL
F.	NULL
&	NULL
Erard	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
2955-2959	NULL
.	NULL

Pontius	NULL
,	NULL
B.	NULL
W.	NULL
&	NULL
Berg	NULL
,	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
8403-8407	NULL
.	NULL

Munroe	NULL
,	NULL
S.	NULL
H.	NULL
&	NULL
Dong	NULL
,	NULL
X	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
895-899	NULL
.	NULL

Portman	NULL
,	NULL
D.	NULL
S.	NULL
&	NULL
Dreyfuss	NULL
,	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

13	NULL
,	NULL
213-221	NULL
.	NULL

Wu	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
Cell	NULL
75	NULL
,	NULL
1061-1070	NULL
.	NULL

